Topic |
Short Abstract |
Abstract |
F |
S |
B |
A |
D |
No |
Journal |
Vol |
Page |
Year |
First Author |
R |
Sub |
PEA |
difuranyl-DOB |
bromo-benzodifuranyl-isopropylamine from tetrahydro compound |
x |
| x |
x |
| #1 |
J. Med. Chem. |
41 |
5148 |
1998 |
M. A. Parker |
1 |
Lil |
| p-di-Me-hydroquinone |
p-di-Me-hydroquinone from p-di-Me-phenol through Elbs persulfate oxidation,
mechanism |
| x |
| | | #2 |
J. Chem. Soc. |
- |
2303 |
1948 |
W. Baker |
1 |
Lil |
| (alpha-Me) phenylethylhydrazines |
phenylethyl / isopropyl-hydrazines from styrenes / propenylbenzenes, hydration
to PIA / PEA |
| x |
| | | #3 |
Ber. |
98 |
904 |
1965 |
T. Kauffmann |
1 |
Lil |
| trifluoromethyl-DMA |
trifluoromethyl-DMA from DOI with 1. (CF3CO)2O in toluene 2. CClF2COOMe, CuI, and KF in DMF 3. KOH in iPrOH |
x |
| x |
x |
| #4 |
J. Med. Chem. |
37 |
4346 |
1994 |
D. E. Nichols |
2 |
Lil |
| dihydrofuranyl-DMA analogs |
4-subst. dihydrofuranyl-DMA analogs, rat and hum. 5-HT2A and 1A binding, rat drug discrimination, DOB analog is 20 times more active in drug
discrimination |
x |
| x |
x |
| #5 |
J. Med. Chem. |
39 |
2953 |
1996 |
A. P. Monte |
1 |
Lil |
| dihydrofuranyl DMA analogs |
4-subst. dihydrofuranyl DMA analogs, rat 5-HT2A binding and rat drug discrimination, DOB analog has the twice the activity of
DOB in drug discrimination and the same binding affinity |
x |
| x |
x |
| #6 |
J. Med. Chem. |
34 |
276 |
1991 |
D. E. Nichols |
2 |
Lil |
| (4,5)-dihydrofuranyl DMA analogs |
(4,5)-dihydrofuranyl DMA analogs, MMDA-2, rat drug discrimination (LSD), less
active than DOM |
x |
| | x |
| #265 |
J. Med. Chem. |
29 |
302 |
1986 |
D. E. Nichols |
3 |
Lil |
| (di-) hydrofuranyl mescaline analogs |
(di)hydrofuranyl mescaline analogs and escaline, hum. 5-HT2A, 2B, and 2C binding and rat drug discrimination |
x |
| x |
x |
| #7 |
J. Med. Chem. |
40 |
2997 |
1997 |
A. P. Monte |
2 |
Lil |
|
(2-COOH)(5-MeO)-benzofuran |
(2-COOH)(5-MeO)-benzofuran from o-hydroxybenzaldehydes and ethyl bromomalonate |
|
x |
| | | #8 |
J. Am. Chem. Soc. |
73 |
872 |
1951 |
S. Tanaka |
2 |
Lil |
| benzofuran |
benzofuran from o-hydroxybenzaldehyde with 1. Cl-acetic acid 2. Ac2O, AcOH, NaOAc |
| x |
| | | #9 |
Org. Synth. Coll. Vol. |
? |
251 |
? |
A. W. Burgstahler |
2 |
Lil |
| subst. 2-COOH-benzofuranes |
subst. 2-COOH-benzofuranes from o-hydroxy-benzaldehydes / -benzophenones with
1. ethyl Br-acetate 2. Ac2O, NaOAc |
| x |
| | | #10 |
Bull. Chem. Soc. Jpn. |
56 |
2762 |
1983 |
T. Suzuki |
2 |
Lil |
| DOM metabolites |
DOM metabolites synthesis: N-Ac-DOM, 4-subst. DMA: CH2OH, CHO, COOH. In a rat metabolism study DOM 8%, 4-CH2OH-DMA 50%, 4-COOH-DMA 28% were found in urine samples. Following paper is on
the next pages (page 158) |
x |
| | | | #11 |
J. Med. Chem. |
14 |
156 |
1971 |
B. T. Ho |
2 |
Lil |
| 4-alkyl-DMA |
4-alkyl-DMA synthesis, human activity, sheep umbilical artery strips contraction |
x |
| x |
x |
| #12 |
J. Med. Chem. |
18 |
1201 |
1975 |
A. T. Shulgin |
2 |
Lil |
| 2,4,5-tri-MeO-PEA, electrolytic reduction |
2,4,5-triMeO-PEA via different old routes, electrolytic reduction, self
experiment |
x |
| | | | #13 |
Recl. Trav. Chim. |
50 |
291 |
1931 |
M. P. J. M. Jansen |
2 |
Lil |
| [
125
I]-DOI |
[
125
I]-DOI from DMA in 6 steps, some [
125
I]-DOI radioligand binding data |
x |
| x |
| | #14 |
J. Med. Chem. |
31 |
5 |
1988 |
R. A. Glennon |
2 |
Lil |
| ALEPH-2 |
ALEPH-2 (= 4-ethylthio-DMA) binding to 5-HT1A, 5-HT2, GABAA (GABA and benzodiazepine site) and some rat behavioural data, no explanation
for putative anxiolytic effect |
| | x |
x |
| #15 |
Arch. Pharmacol. |
354 |
579 |
1996 |
M. Reyes-Parada |
2 |
Lil |
| | | | | | | | | | | | | | | |
naphtyl-ethylamines |
2-(7-)MeO-naphtyl-isopropylamines |
2-(7-)MeO-naphtyl-isopropylamines and ethylamines via naphtaldehydes and
nitroethenes / nitropropenes |
x |
| | | | #311 |
J. Med. Chem. |
38 |
2050 |
1995 |
M. Langlois |
3 |
Lil |
| 7-MeO-1-naphtyl-ethylamine, N-methylation |
7-MeO-1-naphtyl-ethylamine from 7-MeO-naphtyl-1-acetic acid, N-methylation via
trifluoroacetamide methylation with MeI, melatonine analogues |
x |
| | | | #321 |
J. Med. Chem. |
37 |
3231 |
1994 |
P. Depreux |
3 |
Lil |
| | | | | | | | | | | | | | | |
benzaldehydes |
benzaldehydes |
benzaldehydes from toluenes with ferrous sulphate and cupric acetate in high
yields |
| x |
| | | #47 |
patent |
US |
4,146,582 |
1979 |
P. Maggioni |
1 |
Lil |
| | | | | | | | | | | | | | | |
Duff arom. aldehyde synthesis |
hexamethylenetetramine formylation |
hexamethylenetetramine formylation of 2,4,5-trimethoxy-3-methyl-benzene and
2-hydroxy-4,5-dimethoxy-3-methyl-benzene, yield 58%, nitrostyrene with
nitromethane, reduction with LiAlH4 to PEA |
| x |
| | | #521 |
Chem. Pharm. Bull. |
30 |
4170 |
1982 |
K. Matsuo |
5 |
Lil |
| p-formylation with hexamethylenetetramine / TFA |
p-formylation of subst. benzenes with hexamethylenetetramine / TFA, yields are
moderately to good |
| x |
| | | #528 |
J. Org. Chem. |
37 |
3972 |
1972 |
W. E. Smith |
5 |
Lil |
| 3-formyl-indole with hexamethylenetetramine / AcOH |
formylation of indole with hexamethylenetetramine / AcOH, yield 25% |
| x |
| | | #529 |
J. Org. Chem. |
38 |
4002 |
1973 |
A. Chatterjee |
5 |
Lil |
| 2-OH-3,4-diMe-benzaldehyde |
2-OH-3,4-diMe-benzaldehyde from 2-OH-3,4-diMe-benzene with
hexamethylenetetramine / AcOH, yield 33% |
| x |
| | | #535 |
J. Chem. Soc. |
- |
820 |
1953 |
W. Baker |
5 |
Lil |
| | | | | | | | | | | | | | | |
phenolether cleavage |
phenolic compounds |
a high yield PTC phenolether cleavage procedure, many substrates |
| x |
| | | #63 |
Synth. |
- |
437 |
1985 |
S. Andersson |
1 |
Lil |
| | | | | | | | | | | | | | | |
benzofuran tryptamine analogs |
benzofuran tryptamine analogs |
5-MeO-DMT and 5-MeO-alpha-Me-T benzofuran analogs, 3 - 6 times lower affinity
to rat 5-HT2A, 2 times lower to rat 5-HT1A receptor |
x |
| x |
| | #16 |
J. Med. Chem. |
35 |
2061 |
1992 |
Z. Tomaszewski |
2 |
Lil |
| | | | | | | | | | | | | | | |
tryptamines w/o indole |
DMT-2-COOR |
DMT-2-COOR from 2-dimethylaminopropyl-acetoacetate and aniline |
| x |
| | | #17 |
Arch. Pharm. |
311 |
954 |
1978 |
C. H. Brieskorn |
1 |
Lil |
| tryptamine |
tryptamine from 2-chloropropyl-acetoacetate or -malonate |
x |
| | | | #18 |
Synth. |
- |
335 |
1974 |
Cs. Szántay |
1 |
Lil |
| 5-OH-T |
5-OH-T from BzO-aniline and phtalimidopropyl-acetoacetate (19% over all) |
x |
| | | | #19 |
J. Chem. Soc. |
- |
2919 |
1961 |
L. Bretherick |
1 |
Lil |
| 5-OH-T, 5,6-diOH-T |
5-OH-T and 5,6-di-OH-T from alpha-dimethylamino-MeO-PEA with ferricyanide |
x |
| | | | #20 |
J. Chem. Soc. |
- |
1165 |
1954 |
J. Harley-Mason |
1 |
Lil |
| alpha-dimethylamino-PEA |
alpha-dimethylamino-PEA from nitrostyroles and Li-acetamide |
| x |
| | | #21 |
Angew. Chem. |
83 |
542 |
1971 |
D. Seebach |
1 |
Lil |
| various indoles and T |
indoles and tryptamines from indolines from (alpha-dimethylamino-)PEA |
x |
| | | | #22 |
Bull. Soc. Chim. Fr. |
- |
1335 |
1966 |
M. Julia |
1 |
Lil |
| 5-MeO-T, 5-EtO-T |
5-MeO/EtO-tryptamine from phenylhydrazines and aminobutyraldehyde acetal with
ZnCl2 (poor yield) |
x |
| | | | #23 |
Ann. |
516 |
81 |
1935 |
T. Hoshino |
1 |
Lil |
| tryptamine |
tryptamine from phenylhydrazine and aminobutyraldehyde acetal with ZnCl2 (45%) |
x |
| | | | #24 |
J. Chem. Soc. |
- |
270 |
1911 |
A. J. Ewins |
1 |
Lil |
| 7-MeO-T |
7-MeO-tryptamine from MeO-phenylhydrazine and aminobutyraldehyde acetal with
ZnCl2, poor yield |
x |
| | | | #25 |
Ber. |
63 |
2102 |
1930 |
E. Späth |
1 |
Lil |
| 4/7-MeO-T |
4- / 6-MeO-tryptamine from MeO-phenylhydrazine and aminobutyraldehyde acetal
with ZnCl2 (30% 6-MeO-T) |
x |
| | | | #26 |
Ber. |
63 |
120 |
1930 |
E. Späth |
1 |
Lil |
| IAA |
indolacetic acid from phenylhydrazine and dimethoxybutyrate with sulfuric acid
(21%) |
| x |
| | | #27 |
J. Am. Chem. Soc. |
73? |
5155 |
1951 |
M. W. Bullock |
1 |
Lil |
| tryptamines |
tryptamine from phenylhydrazine and chlorobutyraldehyde in EtOH / H2O (70%) |
x |
| | | | #28 |
CA |
79 |
146321h |
1973 |
I. I. Grandberg |
1 |
Lil |
| alpha,N-DMT |
alpha,N-DMT from indolylacetone and methylamine with H2, Pd/C, methods references for sec. amines |
x |
| | | | #29 |
Tet. Lett. |
43 |
4183 |
1979 |
D. B. Repke |
1 |
Lil |
| 5-subst. tryptamines |
tryptamines through Abramovich-Shapiro (formic acid) synthesis |
x |
| | | | #31 |
J. Med. Chem. |
37 |
4307 |
1994 |
T. Güngör |
1 |
Lil |
| subst. N,N-dialkyltryptamines |
tryptamines through Abramovich-Shapiro synthesis (HCl / EtOH),
quart.-methylation, demethylation or Batcho-Leimgruber indole synthesis,
Speeter-Anthony tryptamine synthesis |
x |
| x |
x |
| #32 |
J. Med. Chem. |
25 |
908 |
1982 |
T. B. Kline |
1 |
Lil |
| (5-MeO)tryptamine |
Abramovich-Shapiro tryptamine synthesis from 2-oxo-piperidine-3-carboxylates
and anilines via 1-oxo-beta-carboline |
x |
| | | | #33 |
J. Am. Chem. Soc. |
78? |
4589 |
1956 |
R. A. Abramovich |
1 |
Lil |
| 1-R-tryptamines |
many subst. tryptamines from indoleacetic acids |
x |
| | x |
| #34 |
Bull. Soc. Chim. Fr. |
- |
1411 |
1965 |
M. Julia |
1 |
Lil |
| 1-R-tryptamines |
1-subst. tryptamines from anilines and bromo-acetoacetate |
x |
| | |
| #35 |
Bull. Soc. Chim. Fr. |
- |
1051 |
1962 |
M. Julia |
1 |
Lil |
| 1-R-tryptamines |
1-subst. tryptamines from anilines and bromo-acetoacetamides |
x |
| | |
| #36 |
Bull. Soc. Chim. Fr. |
- |
1056 |
1962 |
M. Julia |
1 |
Lil |
| 1-R-tryptamines |
1-subst. tryptamines from anilines and bromo-acetoacetamides and
-bromo-acetoacetates or from bromoethylindole from tryptophol |
x |
| | x |
| #37 |
Bull. Soc. Chim. Fr. |
- |
1060 |
1962 |
M. Julia |
1 |
Lil |
| ethyl 4-bromoacetoacetate |
ethyl 4-bromoacetoacetate from ethyl acetoacetate and bromine |
| x |
| | | #38 |
J. Org. Chem. |
12 |
346 |
1947 |
A. Burger |
1 |
Lil |
| ethyl 4-bromoacetoacetate |
ethyl 4-bromoacetoacetate from ethyl acetoacetate and bromine |
| x |
| | | #39 |
Ber. |
29 |
1042 |
1896 |
M. Conrad |
1 |
Lil |
| acetoacetamides |
acetoacetamides from acetoacetamide, NaOEt, and alkyliodide |
| x |
| | | #40 |
Monatsh. Chem. |
28 |
1 |
1907 |
H. Meyer |
1 |
Lil |
| ethyl 4-bromoacetoacetate |
ethyl 4-bromoacetoacetate from ethyl acetoacetate and bromine, reaction
mechanism |
| x |
| | | #41 |
J. Am. Chem. Soc.? |
56 |
1655 |
1937 |
M. S. Kharasch |
1 |
Lil |
| alpha-MT |
alpha-MT from Trp |
x |
| | x |
| #42 |
J. Het. Chem. |
13 |
775 |
1976 |
D. B. Repke |
1 |
Lil |
| subst. tryptamines |
many, many tryptamines through Abramovich, indolylacetone reductive amination,
indolylmagnesiumbromide, indolylcarbaldehyde and gramine with nitroalkanes,
tryptamine acylation / LiAlH4 reduction... |
x |
| | | | #43 |
J. Chem. Soc. |
- |
7165 |
1965 |
B. Heath-Brown |
1 |
Lil |
| 5-triazolo-N-Me-piperid-3-yl-indole and -DMT |
5-triazolo-3-N-Me-piperidyl-indole and 5-triazolo-DMT through phenylhydrazine /
aldehyde route, binding data for many 5-HT-receptors, poor binding to 5-HT2 |
x |
| x |
| | #245 |
Bioorg. Med. Chem. Lett. |
6 |
1825 |
1996 |
F. Sternfeld |
3 |
Lil |
| 5-MeO-DMT via tryptophol |
5-MeO-DMT via indole-3-acetonitrile, indole-3-acetic acid, ethyl ester,
Na-reduction to tryptophol, with PBr3 to bromide, with aqu. dimethylamine at 100°C to 5-MeO-DMT or from
5-MeO-trimethylammoniumiodide with 1. AgCl2 2. vacuum destillation, poor yields |
x |
| | | | #315 |
Bull. Chem. Soc. Jpn. |
11 |
221 |
1963 |
T. Hoshino |
3 |
Lil |
| DMT from indole-3-acetic acid or tryptophol |
DMT from indole-3-acetic acid via ethyl ester, amide, LiAlH4 reduction, NMT from tryptophol via bromide (yield 60%), very poor yield |
x |
| | | | #316 |
J. Am. Chem. Soc. |
78 |
3668 |
1956 |
M. S. Fish |
3 |
Lil |
| indolyl-3-acetic acid |
indolyl-3-acetic acid from 1. phenylhydrazine and beta-cyano-propionacetal 2.
hydrolyzation or from indole with diazoesters |
| x |
| | | #322 |
Can. J. Res. Sect. B |
13 |
170 |
1935 |
R. W. Jackson |
3 |
Lil |
| 5-NO2-T and 5-NH2-T |
5-NO2-(N,N-dimethyl-)T and 5-NH2-(N,N-dimethyl-)T from p-NO2-phenylhydrazone and 4-Cl-butyraldehyde (R. Paul, Bull. Soc. Chim. 8, 911 1941
and 15, 197 1984), reaction with aqu. dimethylamine and sodium hydrosulfite
reduction (yield 52%), poor yields |
x |
| | | | #304 |
J. Am. Chem. Soc. |
75? |
1877 |
1953 |
E. Shaw |
3 |
Lil |
| dimethyltryptamines via hydrazine / butyraldehde |
5-subst. dimethyltryptamine from phenylhydrazine and dimethylaminobutyraldehyde
acetal with 4% H2SO4 "original paper" |
| x |
| | | #468 |
J. Org. Chem. |
59 |
3738 |
1994 |
C. Chen |
4 |
Lil |
| | | | | | | | | | | | | | | |
Trp decarboxylation |
tryptamine |
tryptamine from Trp in cyclohexanol with cyclohexanone catalyst (92%) |
x |
| | | | #44 |
Chem. Lett. |
- |
893 |
1986 |
M. Hashimoto |
1 |
Lil |
| tryptamine |
tryptamine from Trp with acetophenone (100%) |
x |
| | | | #45 |
Bull. Soc. Chim. Fr. |
- |
2523 |
1964 |
G. Chatelus |
1 |
Lil |
| | | | | | | | | | | | | | | |
phenylhydrazines |
4-alkyloxyphenylhydrazines |
4-alkyloxyhydrazines from anilines, NaNO2, and SnCl2 / HCl |
| x |
| | | #48 |
CA |
67 |
99842u |
1967 |
M. J. Monballu |
1 |
Lil |
| 4-alkyloxyphenylhydrazines |
4-alkyloxyhydrazines from anilines, NaNO2, sodium sulfite, Zn / acetic acid |
| x |
| | | #49 |
Ber. |
25 |
1842 |
1892 |
J. Altschul |
1 |
Lil |
| 4-alkyloxyphenylhydrazines |
4-EtO-phenylhydrazine through improved Altschul procedure (removing Na salts
against decomposition) |
| x |
| | | #50 |
J. Prakt. Chem. |
96 |
9 |
1918? |
? |
1 |
Lil |
| 4-alkyloxyphenylhydrazines |
4-nPrO-phenylhydrazine through Altschul procedure |
| x |
| | | #51 |
J. Prakt. Chem. |
1? |
120 |
1945 |
? |
1 |
Lil |
| 4-alkyloxyphenylhydrazines |
subst. phenylhydrazines from anisidines with stannous chloride |
| x |
| | | #52 |
Aust. J. Chem. |
27 |
1361 |
1974 |
J. L. Frahn |
1 |
Lil |
| 4-MeO-phenylhydrazine, 4- / 5- / 7-MeO-indole |
4-MeO-phenylhydrazine via SnCl2 route, 4- / 5- / 7-MeO-indole |
| x |
| | » |
#110 |
J. Chem. Soc. |
- |
296 |
1924 |
K. G. Blaikie |
2 |
Lil |
| 4-MeO-phenylhydrazine |
4-MeO-phenylhydrazine from aniline via SnCl2 route at -25°C, high temperature sensitivity of the reaction |
| x |
| | | #469 |
Aust. J. Chem. |
27 |
1361 |
1974 |
J. L. Frahn |
4 |
Lil |
| | | | | | | | | | | | | | | |
DMABA acetals |
chloro-butyraldehyde |
4-chloro-butyraldehyde from 4-chloro-butyrylchloride with formic acid and
ammonium hydroxide |
| x |
| | | #53 |
Tet. Lett. |
39 |
8153 |
1998 |
K. M. Shamsuddin |
1 |
Lil |
| dibutylaminobutyraldehyde acetal |
dibutylamino-butyraldehyde diethylacetal from 4-dibutylamino-propylchloride,
Mg, and triethoxymethane, yield 60%, detailed instructions |
| x |
| | | #54 |
J. Org. Chem. |
18 |
1356 |
1953 |
D. Perrine |
1 |
Lil |
| bromo-butyraldehyde |
4-bromo butyraldehyde from THF, boron bromide, and pyridinium chlorochromate
(PCC), yield 70% |
| x |
| | | #55 |
Heterocycles |
18 |
163 |
1982 |
S. U. Kulkarni |
1 |
Lil |
| dimethylaminobutyraldehyde acetal |
4-dimethylamino-butyraldehyde diethylacetal from available 4-aminobutyraldehyde
diethylacetal, formaldehyde, Ti(OiPr)4, and NaBH4, yield 92% |
| x |
| | | #56 |
Tet. Lett. |
35 |
2401 |
1994 |
S. Bhattacharyya |
1 |
Lil |
| bromo-butyraldehyde acetal |
4-bromo-butyraldehyde acetal from: 1. 4-Bromobutyric acid, boran
dimethylsulfide complex, PCC 2. acetalization |
| x |
| | | #57 |
J. Org. Chem. USSR (Engl.Transl.) |
25 |
1873 |
1989 |
N. I. Bobrova |
1 |
Lil |
| bromo-butyraldehyde acetal |
4-bromo-butyraldehyde acetal from: 1. 4-Bromobutyric acid and boran
dimethylsulfide complex 2. Swern oxidation (DMSO / oxalylchloride) 3.
acetalization, no reaction details |
| x |
| | | #58 |
Tet. Lett. |
29 |
685 |
1988 |
T. V. Lee |
1 |
Lil |
| chloro-butanol |
4-chloro-butanol from THF and HCl gas, yield 55%, detailed instructions |
| x |
| | | #59 |
Org. Synth. Coll. Vol. |
2 |
571 |
1943 |
D. Starr |
1 |
Lil |
| chloro-butanol |
4-chloro-butanol from THF and HCl gas, yield 56% |
| x |
| | | #471 |
J. Am. Chem. Soc. |
56 |
1595 |
1934 |
D. Starr |
4 |
Lil |
| bromo-butanol |
4-bromo-butanol from THF and HBr gas, yield 58% |
| x |
| | | #472 |
Helv. Chim. Acta |
61 |
885 |
1978 |
P. C. Wälchli |
4 |
Lil |
| | modified Rosenmund reduction of acid chlorides using EtiPr2N, pure Pd/C and H2 in acetone |
| x |
| | | #473 |
Recl. Trav. Chim. |
90 |
1323 |
1971 |
J. A. Peters |
4 |
Lil |
| chloro-butyraldehyde |
4-chloro-butyraldehyde acetals from 4-chloro butanol, yield 67% |
| x |
| | | #60 |
J. Chem. Soc. Perk. I |
- |
2353 |
1977 |
C. P. Forbes |
1 |
Lil |
| bromo-butyraldehyde |
4-bromo-butyraldehyde from: 1. THF with HBr 48%, yield 38% 2. PCC, yield 62% |
| x |
| | | #61 |
J. Org. Chem. |
44 |
3230 |
1979 |
E. Vedejs |
1 |
Lil |
| bromo-butyraldehyde acetal |
4-bromo-butyraldehyde dimethylacetal from THF, bromotrimethylsilane, PCC, and
trimethoxymethane, yield 34%, no details |
| x |
| | | #62 |
J. Org. Chem. |
57 |
686 |
1992 |
B. M. Trost |
1 |
Lil |
| PCC oxidation |
PCC = pyridinium chlorochromate oxidation of alcohols to aldehydes, yields 78%
- 100% |
| x |
| | | #467 |
Tet. Lett. |
31 |
2647 |
1975 |
E. J. Corey |
4 |
Lil |
| chloro-butyraldehyde |
chloro butyraldehyde from gamma-butyrolactone via chlorobutyryl chloride with
thionyl chloride and ZnCl2, chlorobutyryl methylanilide with N-methylanilin, yield 75%, and chlorobutyryl
chloride with LiAlH4, yield 25% |
| x |
| | | #470 |
Bull. Chem. Soc. Jpn. |
11 |
446 |
1963 |
Y. Ban |
4 |
Lil |
| aminobutyraldehyde acetal, tryptamine, NMT, DMT |
aminobutyraldehyde diethylacetal from acrolein via cyanpropionacetal,
tryptamine from aminobutyraldehyde acetal and phenylhydrazine, N-methylation
with MeI and purification via benzoylation / hydrolysis (NMT), AgCl2 / vacuum heating (DMT) |
x |
| | | | #474 |
Can. J. Res. |
32? |
592 |
1932? |
R. H. F. Manske |
4 |
Lil |
4-OH-tryptamines |
4-OTHB |
one of the most interesting papers, 4-OTHB from 1,3-cyclohexanedione and
chloroacetaldehyde |
| x |
| | | #64 |
Het. |
22 |
2313 |
1984 |
M. Matsumoto |
1 |
Lil |
| 4-OTHB |
the corresponding patent for 4-OTHB preparation |
| x |
| | | #65 |
CA |
101 |
23319d |
1984 |
M. Matsumoto |
1 |
Lil |
| 4-OTHB |
the corresponding patent for 4-OTHB preparation |
| x |
| | | #66 |
patent |
EP |
101,003 |
1984 |
M. Matsumoto |
1 |
Lil |
| 4-OTHI |
the corresponding patent for 4-OTHI preparation |
| x |
| | | #67 |
CA |
101 |
23331b |
1984 |
M. Matsumoto |
1 |
Lil |
| 4-OTHI |
the corresponding patent for 4-OTHI preparation |
| x |
| | | #68 |
patent |
EP |
101,004 |
1984 |
M. Matsumoto |
1 |
Lil |
| 4-OTHI |
ammonolysis in H2O, purification ? |
| x |
| | | #69 |
CA |
104 |
148736f |
1986 |
K. Goto |
1 |
Lil |
| 4-OTHI |
ammonolysis in H2O, purification ? |
| x |
| | | #70 |
patent |
JP |
60,228,457 |
? |
K. Goto |
1 |
Lil |
| 4-OTHI |
ammonolysis in H2O, purification ? |
| x |
| | | #71 |
CA |
104 |
148737g |
1986 |
K. Goto |
1 |
Lil |
| 4-OTHI |
ammonolysis in H2O, purification ? |
| x |
| | | #72 |
patent |
JP |
60,228,456 |
? |
K. Goto |
1 |
Lil |
| 4-OTHI |
ammonolysis in H2O, purification ? |
| x |
| | | #73 |
CA |
104 |
148738h |
1986 |
K. Goto |
1 |
Lil |
| 4-OTHI |
ammonolysis in H2O, purification ? |
| x |
| | | #74 |
patent |
JP |
60,228,455 |
? |
K. Goto |
1 |
Lil |
| 4-OTHI |
4-OTHB ammonolysis in polyol partial ethers, dehydrogenation, purification ? |
| x |
| | | #75 |
CA |
106 |
67111n |
1987 |
S. Matsuno |
1 |
Lil |
| 4-OTHI |
4-OTHB ammonolysis in polyol partial ethers, dehydrogenation, purification ? |
| x |
| | | #76 |
patent |
JP |
61,180,768 |
? |
S. Matsuno |
1 |
Lil |
| 4-OTHI |
4-OTHB ammonolysis in polyol partial ethers, dehydrogenation, purification ? |
| x |
| | | #77 |
CA |
106 |
67112p |
1987 |
S. Matsuno |
1 |
Lil |
| 4-OTHI |
4-OTHB ammonolysis in polyol partial ethers, dehydrogenation, purification ? |
| x |
| | | #78 |
patent |
JP |
61,180,767 |
? |
S. Matsuno |
1 |
Lil |
| 4-OTHI |
4-OTHI from 2-acetonyl-1,3-cyclohexanedione |
| x |
| | | #79 |
Ann. |
655 |
20 |
1962 |
H. Stetter |
1 |
Lil |
| 4-OTHI |
4-OTHI from 1,3-cyclohexanedione, 2-amino-ethanol, and catalyst |
| x |
| | | #80 |
Tet. Lett. |
37 |
9203 |
1996 |
Y. Aoyagi |
1 |
Lil |
| 4-OTHI |
4-OTHI from 1,3-cyclohexanedione, 2-amino-ethanol, and catalyst |
| x |
| | | #81 |
CA |
102 |
62078q |
1985 |
Ube Industries |
1 |
Lil |
| 4-OTHI |
4-OTHI from 1,3-cyclohexanedione, 2-amino-ethanol, and catalyst |
| x |
| | | #82 |
patent |
JP |
59,144,758 |
? |
Ube Industries |
1 |
Lil |
| 4-OTHI |
4-OH-indole from 4-OTHI from 4-OTHB-3-carboxylic acid (with ammonium carbonate)
from 1,3-cyclohexanedione and ethyl bromo pyruvate |
| x |
| | | #83 |
Recl. Trav. Chim. |
109 |
287 |
1990 |
E. M. M. van den Berg |
1 |
Lil |
| 4-OTHI |
4-OTHI from 4-OTHB-3-carboxylic 4-OTHI from 4-OTHB-3-carboxylic acid with
ammonium salts |
| x |
| | | #84 |
CA |
101 |
7022w |
1984 |
? |
1 |
Lil |
| 4-OTHI |
4-OTHI from 4-OTHB-3-carboxylic 4-OTHI from 4-OTHB-3-carboxylic acid with
ammonium salts |
| x |
| | | #85 |
patent |
JP |
59 05,159 ? |
? |
? |
1 |
Lil |
| 4-OTHI |
4-OTHB-3-carboxylic acid from 1,3-cyclohexanedione and bromo pyruvate or
bromoacetaldehyde diethylacetal. |
| x |
| | | #86 |
Synth. Commun. |
16 |
1635 |
1986 |
Kneen |
1 |
Lil |
| 4-OTHI |
4-OTHI from cyclohexanedione and ethyl vinyl ether via electrolysis and
ammonolysis with ammonium carbonate |
| x |
| | | #87 |
Chem. Lett. |
- |
1603 |
1980 |
S. Torii |
1 |
Lil |
| 4-OTHI |
4-OTHI from 1,3-cyclohexandione + NH3 / H2O + acetic acid 1,2-dibromoethyl ester |
| x |
| | | #88 |
CA |
108 |
94379d |
1988 |
K. Nagao |
1 |
Lil |
| 4-OTHI |
4-OTHI from 1,3-cyclohexandione + NH3 / H2O + acetic acid 1,2-dibromoethyl ester |
| x |
| | | #89 |
patent |
JP |
62,138,469 |
? |
K. Nagao |
1 |
Lil |
| 4-OTHI |
4-OTHI from 4-(2-pyrrolyl)-butyric acid |
| x |
| | | #90 |
CA |
71 |
81163w |
1969 |
M. Julia |
1 |
Lil |
| 4-OTHI |
4-OTHI from 1,3-cyclohexanedione and aminosugars |
| x |
| | | #91 |
J. Chem. Soc. Perk. I |
- |
1237 |
1974 |
A. G. Sánchez |
1 |
Lil |
| 4-OTHI |
4-OTHI from 1,3-cyclohexanedione and aminoacetaldehyde dimethylacetal |
| x |
| | | #92 |
Chem. Commun. |
- |
1429 |
1968 |
J. M. Bobbitt |
1 |
Lil |
| 4-OTHI |
4-OTHI from 1,3-cyclohexanedione and aminoacetaldehyde dimethylacetal |
| x |
| | | #93 |
J. Org. Chem. |
43 |
3541 |
1968 |
J. M. Bobbitt |
1 |
Lil |
| 4-OH-indole |
4-OH-indole from 4-OTHI dehydrogenation, synthesis of 4-OH-tryptamines |
x |
| | | | #94 |
J. Het. Chem. |
14 |
71 |
1977 |
D. B. Repke |
1 |
Lil |
| 4-OH-indole |
4-OH-indole from 4-OTHI dehydrogenation + some references |
| x |
| | | #95 |
J. Org. Chem. |
36 |
1232 |
1971 |
W. A. Remers |
1 |
Lil |
| 4-OH-indole |
4-OH-indole from 4-OTHI dehydrogenation |
| x |
| | | #96 |
CA |
103 |
215169t |
1985 |
H. Fukumitsu |
1 |
Lil |
| 4-OH-indole |
4-OH-indole from 4-OTHI dehydrogenation |
| x |
| | | #97 |
patent |
JP |
60,152,462 |
? |
H. Fukumitsu |
1 |
Lil |
| 4-OH-indole |
4-OH-indole from 4-OTHI dehydrogenation |
| x |
| | | #98 |
CA |
107 |
236506y |
1987 |
Nagao |
1 |
Lil |
| 4-OH-indole |
4-OH-indole from 4-OTHI dehydrogenation |
| x |
| | | #99 |
patent |
JP |
62 63,563 |
? |
Nagao |
1 |
Lil |
| 4-OH-indole |
4-OH-indole from 4-OTHI dehydrogenation |
| x |
| | | #100 |
Chem. Ber. |
101 |
2605 |
1968 |
H. Plieninger |
1 |
Lil |
| 4-OH-indole |
4-OH-indole from 4-OTHI dehydrogenation via halogenation with CuX2 and dehydrohalogenation with Li2CO3 + LiX in DMF |
| x |
| | | #101 |
Het. |
23 |
165 |
1985 |
M. Matsumoto |
1 |
Lil |
| 4-OH-tryptamines |
4-AcO-indole to many 4-OH-tryptamines via glyoxylamides |
x |
| | | | #102 |
J. Het. Chem. |
19 |
845 |
1982 |
D. B. Repke |
1 |
Lil |
| 4-OH-tryptamines |
synthesis of 4-MeO-indole, reaction with 1-dimethylamino-2-nitroethylene, LAH
reduction to tryptamines |
x |
| | | | #103 |
J. Het. Chem. |
18 |
175 |
1981 |
D. B. Repke |
1 |
Lil |
| 4-subst. indoles |
synthesis of 4-NH2 / COOCH3 / CH3 / OH / MeO / BnO-indoles |
| x |
| | | #104 |
Het. |
16 |
1119 |
1981 |
L. I. Kruse |
1 |
Lil |
| 4-OH-indole, 4-NH2-indole |
4-OH-indole and 4-NH2-indole from 2,6-dinitro-toluene in 3 steps, overall yields ~65% |
| x |
| | | #105 |
Bull. Chem. Soc. Jpn. |
62 |
3742 |
1989 |
H. Tanaka |
2 |
Lil |
| 4-OTHI |
4-OTHI-2-COOEt-3-CH2COOEt from 1,3-cyclohexanedione and isonitrosoketone with Zn, AcONa, AcOH,
yield 36% (Knorr's reaction) |
| x |
| | | #106 |
CA |
66 |
115537k |
1967 |
A. N. Kost |
2 |
Lil |
| 4-nitroindole |
4-nitroindole from 2-methyl-3-nitroaniline |
| x |
| | | #107 |
Org. Synth. Coll. Vol. |
8 |
493 |
1993 |
J. Bergmann |
1 |
Lil |
| 4-nitroindole |
4-nitroindole from 2,6-dinitrotoluene |
| x |
| | | #108 |
Tet. Lett. |
24 |
3665 |
1983 |
J. Bergmann |
1 |
Lil |
| 4-nitroindole |
4-NO2-indole, yield 57%, 4-NO2-7-Me-indole, yield 41%, from (2-Me-) 6-methyl-3-nitroanilines with 1.
trimethyl orthoformate, pTsOH 2. NaOEt, diethyl oxalate in DMF |
| x |
| | | #109 |
Tet. |
46 |
6085 |
1990 |
J. Bergmann |
2 |
Lil |
| 4-MeO-phenylhydrazine, 4- / 5- / 7-MeO-indole |
4-MeO-phenylhydrazine via SnCl2 route, 4- / 5- / 7-MeO-indole via 2-NO2-MeO-toluene, 2-NO2-MeO-phenylpyruvuc acid, and indole-2-carboxylate |
| x |
| | | #110 |
J. Chem. Soc. |
- |
296 |
1924 |
K. G. Blaikie |
2 |
Lil |
| 4-aminoindole, indoles |
Indoles, 4-aminoindole from indole (!) |
| x |
| | | #111 |
Chem. Pharm. Bull. |
29 |
726 |
1981 |
M. Somei |
1 |
Lil |
| 4-subst. indoles |
4-OH-indole from 4-aminoindole from 4-nitroindole from 2,6-dinitrotoluene |
| x |
| | | #112 |
Chem. Pharm. Bull. |
29 |
3145 |
1981 |
M. Somei |
1 |
Lil |
| II, III |
synthesis of II and III |
| x |
| | | #113 |
Het. |
38 |
2585 |
1994 |
A. Ojida |
1 |
Lil |
| II |
synthesis of II |
| x |
| | | #114 |
J. Org. Chem. |
58 |
3960 |
1990 |
M. Aso |
1 |
Lil |
| II |
synthesis of II |
| x |
| | | #115 |
Het. |
35 |
33 |
1993 |
M. Aso |
1 |
Lil |
| II |
synthesis of II |
| x |
| | | #116 |
Het. |
31 |
1003 |
1190 |
M. Aso |
1 |
Lil |
| propynyl sulfonium salt |
prop-2-ynyl sulfonium salt (CHCCH2S+R2 Cl-) preparation |
| x |
| | | #117 |
J. Chem. Soc. |
- |
1904 |
1996 |
G. D. Appleyard |
1 |
Lil |
| propynyl sulfonium salt |
prop-2-ynyl sulfonium salt (CHCCH2S+R2 Cl-) preparation |
| x |
| | | #118 |
J. Chem. Soc. Chem. Commun. |
- |
534 |
1971 |
J. W. Batty |
1 |
Lil |
| Mannich / Eschenmoser's salts |
Mannich salts (Eschenmoser's salt, CH2NR2
+
Cl
-
) from amine, alcohol, aldehyde, and methyltrichlorosilane, cheap and nontoxic
procedure |
| x |
| | | #119 |
Synth. |
- |
228 |
1986 |
C. Rochin |
1 |
Lil |
| Mannich / Eschenmoser's salts |
Mannich salts (Eschenmoser's salt, (CH2)3N
+
Cl
-
) from tetramethylenediamine, and trimethylsilyl chloride |
| x |
| | | #497 |
J. Org. Chem. |
45 |
524 |
1980 |
T. A. Bryson |
4 |
Lil |
| 4-iodo-IV (R = Bn, allyl), "ene"-reaction |
4-iodo-IV (R = Bn, allyl) from o-iodo-N-allyl-N-R-anilines with zirconium
reagent, "ene"-reaction with Eschenmoser's salts to N-Et2 and N-"piperidyl"-tryptamines V. |
x |
x |
| | | #120 |
J. Am. Chem. Soc. |
113 |
4685 |
1991 |
J. H. Tidwell |
1 |
Lil |
| 4-iodo-IV (R = Bn, allyl) |
4-iodo-IV (R = Bn, allyl), same procedure |
| x |
| | | #121 |
J. Am. Chem. Soc. |
116 |
11797 |
1994 |
J. H. Tidwell |
1 |
Lil |
| 4-iodo-IV (R = allyl, CO2Et) |
4-iodo-IV (R = allyl, CO2Et), same procedure |
| x |
| | | #122 |
J. Org. Chem. |
59 |
7164 |
1994 |
J. H. Tidwell |
1 |
Lil |
| IV (R = SO2Ph) |
IV (R = SO2Ph) via 4-bromo-N-propargyl-sulfanilide with tributylstannane / cat. AIBN,
promising procedure |
| x |
| | | #123 |
J. Am. Chem. Soc. |
110 |
4796 |
1988 |
D. L. Boger |
1 |
Lil |
| IV (R = Ac) |
IV (R = Ac) via o-Iodo-N-propargyl-acetanilide with CrCl2 and cat. NiCl2 |
| x |
| | | #124 |
Tet. Lett. |
35 |
1601 |
1994 |
D. M. Hodgson |
1 |
Lil |
| IV (R = Ac, part of a mixture) |
IV (R = Ac, part of a mixture) via o-bromo-N-allyl-acetanilide with
tributylstannane / cat. AIBN |
| x |
| | | #125 |
Tet. Lett. |
29 |
45 |
1988 |
J. P. Dittami |
1 |
Lil |
| IV (R = Ac) |
IV (R = Ac) via o-Iodo-N-allyl-acetanilide with Pd(OAc)2 / PPh3 |
| x |
| | | #126 |
Tet. Lett. |
29 |
4325 |
1988 |
D. Burns |
1 |
Lil |
| IV (R = SO2Ph) |
IV (R = SO2Ph) via 4-iodo-N-allyl-sulfanilide with Pd(OAc)2 |
| x |
| | | #127 |
J. Chem. Soc. Perk. I |
- |
1941 |
1993 |
T. Sakamoto |
1 |
Lil |
| IV (R = SO2Ph-4-Me) |
IV (R = SO2Ph-4-Me) via 2-isopropenyl-tosylanilide with Pd(OAc)2 |
| x |
| | | #128 |
J. Org. Chem. |
61 |
3584 |
1996 |
R. C. Larock |
1 |
Lil |
| 4-OH-7-Me-indole |
4-OH-7-Me-indole from 4-BzO-indole-2-COOEt via 7-formylation, 2-saponification,
2-decarboxylation, 7-reduction, and catalytic debenzylation, also many
different reactions with 2,3-subst. 4-OH/BzO-indoles |
| x |
| | | #129 |
Helv. Chem. Acta |
54 |
2411 |
1971 |
F. Seemann |
2 |
Lil |
| 3-subst. 4-OH-indoles |
3-subst. 4-OH-indoles from OTHI-2-COOR through saponification, decarboxylation,
and dehydration |
| x |
| | | #130 |
Z. Chem. |
6 |
183 |
1966 |
S. Hauptmann |
2 |
Lil |
| 4-OH-indole-3-carbaldehyde |
4-BzO/alkylO-indole-3-carbaldehyde from indole-3-carbaldehyde in one-pot with
1. thallium(III)-trifluoroacetate (TTFA) in TFA 2. I2 and CuI in DMF 3. NaOalkyl / NaOBz, yields: MeO 86%, BzO 58%, EtO 50%,
(4-OH-synth: Het. 24, 3065 1986 M. Somei) |
| x |
| | | #131 |
Het. |
22 |
797 |
1984 |
M. Somei |
2 |
Lil |
| 4-OH-indole-3-carbaldehyde |
4-OH-indole-3-carbaldehyde from indole-3-carbaldehyde in a one-pot synthesis
with 1. thallium(III)-trifluoroacetate (TTFA) in TFA 2. CuSO4 in DMF 3. H2O, 120°C, yield 70%, no reaction details, melatonine from
1-OH-N-Ac-tryptamine, yield 86%, no details |
| x |
| | | #132 |
Het. |
43 |
1855 |
1996 |
M. Somei |
2 |
Lil |
| 4-OH-indole-3-carbaldehyde |
psilocin from indole-3-carbaldehyde, 4-BzO-indole-3-carbaldehyde (improved
yield 72%), 3-acetonitrile (NaBH4, NaCN, MeOH, HCONH2), 3-ethylamine (LiAlH4, Et2O), 3-dimethylaminoethyl (NaCNBH4, HCHO, yield 97%), psilocin (H2, Pd/C), overall yield 50% |
| x |
| | | #133 |
Het. |
49 |
451 |
1998 |
F. Yamada |
5 |
Lil |
| 4-H / Me / MeO / OAc / OSO2CF3-indoles |
subst. indoles, e.g. 4-H- / -Me- / -MeO- / -OAc- / -OSO2CF3 / 5-Br-indoles, from N-tosyl-2-vinyl-anilines with tributylvinylstannan / (Ph3P)4Pd, from 2-Br-anilines from 2-Br-nitrobenzenes |
| x |
| | | #134 |
J. Org. Chem. |
53 |
1170 |
1988 |
M. E. Krolski |
2 |
Lil |
| 2-Br-anisidine |
2-Br-anisidine = 2-Br-4-MeO-aniline from anisidine with Br2 / AcOH, yield 40% |
| x |
| | | #407 |
Tet. |
48 |
6875 |
1992 |
A. J. Clark |
4 |
Lil |
| 2-Br-anisidine |
2-Br-anisidine = 2-Br-4-MeO-aniline via 3-Br-phenol, 3-Br-4-NO2-phenol, 2-Br-4-MeO-nitrobenzene, over all yield 35% |
| x |
| | | #408 |
Tet. Lett. |
28 |
6389 |
1987 |
C. Wright |
4 |
Lil |
| 4-Cl-DMT |
4-Cl-DMT from 4-Cl-indole via Speeter-Anthony synthesis |
x |
| | | | #476 |
Can. J. Chem. |
41 |
2586? |
1963 |
McKay |
4 |
Lil |
| bufoviridine |
bufoviridine = bufotenine-O-sulfate isolation and identification, TLC Rf and
colour reactions for many related compounds |
| | | | | #237 |
Biochem. Pharmacol. |
2 |
270 |
1959 |
V. Erspamer |
3 |
Lil |
| 4-NO2- / NH2- / Cl-tryptamines |
4-NO2- / NH2- / Cl-(N,N-dimethyl-)tryptamines, N-substitutions as LSD analogs.
chlorobutyraldehyde / hydrazines, Speeter / Anthony, catalytic hydrogenation or
dithionite reduction of NO2 to NH2 |
x |
| | | | #238 |
Can. J. Chem. |
41 |
2585 |
1963 |
J. B. McKay |
3 |
Lil |
| selenopsilocin |
N1-seleno psilocin analog, 5-step synthesis, "strong binding with
serotonergic sites", no details on binding data |
x |
| x |
| | #239 |
Het. |
34 |
1737 |
1992 |
A. Dari |
3 |
Lil |
| psilocin / psilocybin analogs |
psilocin / psilocybin analogs: psilocybin phosphoryloxy position isomers,
4-OH-tryptamine O and N substitutions (O-alkyl, O-esters, O-sulfate),
psilocybin N-substitution analogs, UV spectra, colour reactions |
x |
| | | | #240 |
Helv. Chim. Acta |
42 |
2073 |
1959 |
F. Troxler |
3 |
Lil |
| psilocin, bufotenine pKA, part. coeff., NMR |
psilocin, bufotenine: pKA, part. coeff., solution NMR |
| | | | | #241 |
J. Med. Chem. |
24 |
207 |
1981 |
G. P. Migliaccio |
3 |
Lil |
| 2'-
14
C- / N-Me-
14
C-psilocin metabolism |
2'-
14
C- / N-Me-
14
C-psilocin synthesis, rat metabolism and excretion |
x |
| | | | #242 |
Biochem. Pharmacol. |
11 |
261 |
1962 |
F. Kalberer |
3 |
Lil |
| 4 / 5-AcO / OH-, 6 / 7-OH-indoles |
4- / 5-OH-indole via Nemitzescu synth. via 2-NO2-6-/5-OH-benzaldehyde, acetoxy-2,beta-dinitrostyrene reduction with Fe / AcOH,
4-/5-Acetoxy-indole, 6-/7-OH-indole via 2-NO2-4-/3-OH-toluene, 2-NO2-4-/3-BzO-hippuric acid, 6-/7-BzO-indole-carboxylate |
| x |
| | | #402 |
J. Chem. Soc. |
- |
1605 |
1948 |
R. J. S. Beer |
4 |
Lil |
| 4-BzO-indole, 4-BzO-/5-MeO-/H-tryptamines |
4-BzO-indole via improved Leimgruber-Batcho route, alpha-subst.
4-BzO-/5-MeO-/H-tryptamines via indolylnitroalkanes with 2-NO2-propene /-butene, tryptamines with Ni2B reduction |
| x |
| | | #403 |
J. Org. Chem. |
51 |
4294 |
1986 |
D. H. Lloyd |
4 |
Lil |
| psilocybin and psilocin extraction |
psilocin and psilocybin extraction, UV and IR spectra, colour reactions,
synthesis |
x |
| | | | #450 |
Helv. Chim. Acta |
42 |
1557 |
1959 |
A. Hofmann |
4 |
Lil |
| meridianines |
meridianines (Br-subst. (2-aminopyrimid-4-yl)-4-OH-indoles) from the tunicate
Aplidium meridianum |
| | | | | #198 |
J. Nat. Prod. |
61 |
1130 |
1998 |
L. H. Franco |
2 |
Lil |
| | | | | | | | | | | | | | | |
phenolic OH phosphorylation |
Tyr-O-phosphate |
O-phospho-Tyr from tyrosine with pyrophosphoric acid (from P2O5 and phosphoric acid) at 80°C for 24 h, pure product after precipitation,
yield: 50% - 91% |
| x |
| | | #135 |
Synth. |
- |
30 |
1938 |
P. F. Alewood |
2 |
Lil |
| aryl-/alkyl-phosphates |
aryl- / alkyl-phosphates from phenols / alcohols with 1. POCl3 2. H2O, 80°C, yields75% - 85% |
| x |
| | | #136 |
Synth. |
- |
704 |
1974 |
G. R. Owen |
2 |
Lil |
| aryl-/alkyl-phosphates |
aryl- / alkyl-phosphates from phenols / alcohols with pyrophosphoric acid (from
P2O5 and phosphoric acid), CCl3CN / NEt3 for non-reactive educts, no yields given |
| x |
| | | #137 |
Bull. Chem. Soc. Jpn. |
54 |
1891 |
1981 |
H. Yamaguchi |
2 |
Lil |
| alkyl-dichlorophosphates |
alkyl-dichlorophosphates from alcohols with POCl3 / NEt3, quantitative yields |
| x |
| | | #138 |
Tet. Lett. |
26 |
1167 |
1985 |
R. L. Magolda |
2 |
Lil |
| aryl-dichlorophosphates |
aryl-dichlorophosphates from phenols with POCl3 / NEt3 or pyridine, yields ~75% |
| x |
| | | #139 |
J. Chem. Soc. |
31 |
575 |
1966 |
?. Pinkus |
2 |
Lil |
| phenyl-dichlorophosphate |
phenyl-dichlorophosphates from phenol with in POCl3, yield 70% |
| x |
| | | #140 |
Chem. Pharm. Bull. |
21 |
202 |
1973 |
T. Koizumi |
2 |
Lil |
| nucleotides |
nucleotides from nucleosides with 1. quinoline-8-phosphate (from 8-OH-quinoline
and phosphoryl chloride, yield 70%), CuCl2 in pyridine 2. acetic acid, yields 59% - 75%, lit. review |
| x |
| | | #141 |
Chem. Pharm. Bull. |
25 |
2121 |
1977 |
H. Takaku |
2 |
Lil |
| oligo nucleotides |
oligonucleotides with phosphotriester method |
| x |
| | | #142 |
Can. J. Chem. |
49 |
3004 |
1971 |
T. Neilson |
2 |
Lil |
| oligo nucleotides |
oligonucleotides with phosphotriester method |
| x |
| | | #143 |
Chem. Ber. |
102 |
2362 |
1969 |
F. Eckstein |
2 |
Lil |
| oligo nucleotides |
oligonucleotides with phosphotriester method |
| x |
| | | #144 |
J. Org. Chem. |
38 |
245 |
1973 |
J. C. Catlin |
2 |
Lil |
| oligo nucleotides |
oligonucleotides with phosphotriester method |
| x |
| | | #145 |
J. Am. Chem. Soc. |
91 |
3350 |
1969 |
R. L. Letsinger |
2 |
Lil |
| nucleoside-2',3'-cyclic phosphates |
nucleoside-2',3'-cyclic phosphates with phosphotriester method,
5-Cl-1-Me-imidazole catalyst |
| x |
| | | #146 |
J. Chem. Soc. Perk. I |
- |
2513 |
1973 |
J. H. van Boom |
2 |
Lil |
| nucleoside-2',3'-cyclic phosphates |
nucleoside-2',3'-cyclic phosphates with phosphotriester method,
(5-Cl-)1-Me-imidazole catalyst |
| x |
| | | #147 |
Nucleic. Acids Res. |
3 |
2731 |
1976 |
J. H. van Boom |
2 |
Lil |
| 5-Cl-1-Et-2-Me-imidazole |
reaction of phenyl-phosphoro-dichloridate with 4-NO2-phenol and cat. 5-Cl-1-Et-2-Me-imidazole |
| x |
| | | #556 |
J. Chem. Soc. Chem. Commun. |
- |
802 |
1977 |
C. B. Reese |
5 |
Lil |
| subst. 5-Cl-imidazoles |
reaction of phenyl-phosphoro-dichloridate with riboses and cat.
5-Cl-1-Et-2-Me-imidazole or 5-Cl-1-Me-imidazole, no success with 2,6-lutidine
or pyridine |
| x |
| | | #557 |
J. Chem. Soc. Chem. Commun. |
- |
869 |
1971 |
J. H. van Boom |
5 |
Lil |
| POCl3, 5-Cl-1-Et-2-Me-imidazole |
subst. phenyl-phosphoro-dichloridate from phenol, POCl3, and cat. 5-Cl-1-Et-2-Me-imidazole |
| x |
| | | #555 |
Synth. |
- |
136 |
1979 |
R. Arentzen |
5 |
Lil |
| | | | | | | | | | | | | | | |
indoles |
subst. indoles |
subst. indoles from anilinoacetaldehyd acetals with trifluoroacetic anhydride
from anilines and bromoacetaldehyde acetals |
| x |
| | | #148 |
J. Org. Chem. |
46 |
778 |
1981 |
J. E. Nordlander |
1 |
Lil |
| subst. indoles |
subst. indoles from methylsulfonyl-anilinoacetaldehyde acetals with TiCl4 from methylsulfonyl-aniline and bromoacetaldehyde acetal with NaH |
| x |
| | | #149 |
J. Org. Chem. |
49 |
249 |
1984 |
R. J. Sundberg |
1 |
Lil |
| 1-carboxymethyl-3-propyl-indole |
1-carboxymethyl-3-propyl-indole from N-carboxymethyl-N-(2-oxopentyl)-aniline
with PPA from N-(2-oxopentyl)-aniline |
| x |
| | | #150 |
J. Chem. Soc. Perk. I |
- |
73 |
1986 |
T. Shono |
1 |
Lil |
| 5-F-indole, 5-F-DMT, 5-F-DET |
5-F-indole, 5-F-DMT, 5-F-DET, 7-MeO-1-naphtyl-ethylamine, N-methylation via
trifluoroacetamide methylation with MeI, melatonine analogs |
x |
| | | » |
#321 |
J. Med. Chem. |
37 |
3231 |
1994 |
P. Depreux |
3 |
Lil |
| 5-F-6-Cl-indole, 5-HT2C agonists, 1-isotryptamines |
5-F-6-Cl-indole from subst. 2-Br-aniline via trifluoroacetanilide,
3-OH-2,3-dihydroindole with MeLi, t-BuLi, and chloracetaldehyde at -100°C,
indole with 1. p-TsA 2. NaOH |
x |
| x |
| » |
#332 |
J. Med. Chem. |
40 |
2762 |
1997 |
M. Bös |
3 |
Lil |
| 7-Me-, 5,7-dichloro-, 5-BzO-7-Me-, 5-MeO-indole |
7-Me-, 5,7-dichloro-, 5-BzO-7-Me-, 5-MeO-indole via Japp-Klingemann / Fischer
indole synth. from subst. anilines, characterization of intermediate
phenylhydrazones or azoesters |
| x |
| | | #390 |
J. Chem. Soc. |
- |
7185 |
1965 |
B. Heath-Brown |
4 |
Lil |
| 5-MeO-, 5,6-diMeO-, 6-EtO-indole, 5-MeO-T, 5-MeO-ET |
5-MeO-indole via Japp-Klingemann / Fischer indole synth. from p-anisidine,
yield 40% over all, 5-MeO-T via Speeter-Anthony, 5-MeO-N-Et-T with 1.
acetylchloride 2. LiAlH4, 5,6-dimethoxy- and 6-EtO-indole from subst. 2-nitro-beta-nitrostyrenes |
| x |
| | | #391 |
Recl. Trav. Chim. |
80 |
313 |
1961 |
T. Kralt |
4 |
Lil |
| 5-HexO-indole, 5-HexO-ET |
5-HexO-N-Et-T from p-HexO-aniline via Japp-Klingemann / Fischer indole synth.
and Speeter-Anthony tryptamine synth. |
| x |
| | | #392 |
CA |
64 |
11180a |
1965 |
- |
4 |
Lil |
| subst. indoles |
subst.indoles from subst. anilines via 2-amino-chloroacetophenones with
chloroacetonitrile, indoles with NaBH4 in refluxing dioxane, 5-MeO-indole yield 36% over all |
| x |
| | | #393 |
J. Org. Chem. |
44 |
578 |
1979 |
T. Sugasawa |
4 |
Lil |
| subst. indoles |
subst. indoles from subst. 2-Br-anilines, N-vinyl-pyrrolidone, triethylamine,
tri-O-tolylphosphine, and Pd(III)acetate, yields 40 - 56% |
| x |
| | | #394 |
J. Het. Chem. |
24 |
1555 |
1987 |
A. Kasahara |
4 |
Lil |
| indole-2-carboxylate |
indole-2-carboxylate from subst. 2-nitro-toluene via 2-nitro-phenylpyravate
salt with diethyloxalate and potassium, indole-2-carboxylate with H2 / Pt in AcOH, over all yield 49% |
| x |
| | | #395 |
Org. Synth. Coll. Vol. |
5 |
567 |
1973 |
W. E. Noland |
4 |
Lil |
| indole |
indole from 2-Me-formanilide and potassium t-butoxide at up to 350°C,
yield 79% |
| x |
| | | #396 |
Org. Synth. Coll. Vol. |
3 |
479 |
? |
F. T. Tyson |
4 |
Lil |
| indole |
indole from 2-Me-formanilide and potassium t-alkoxides, yield 79%, see ref.
#0395 |
| x |
| | | #397 |
J. Am. Chem. Soc. |
63 |
2024 |
1941 |
F. T. Tyson |
4 |
Lil |
| subst. indoles via Leimgruber-Batcho review |
subst. indoles via Leimgruber-Batcho method, extensive review |
| x |
| | | #398 |
Het. |
22 |
195 |
1984 |
R. D. Clark |
4 |
Lil |
| 5-MeO-indole from 5-Bz-O-indole, 5 subst. DMT |
5-MeO-indole from 5-Bz-O-indole with 1. H2, Pd/C 2. dimethylsulfat, 5 subst. DMT via Speeter-Anthony, 1-alkylation with
MeI and sodium amide in liqu. ammonia |
x |
| | | | #400 |
J. Am. Chem. Soc. |
23 |
1977 |
1958 |
F. Benington |
4 |
Lil |
| 6-subst.indoles |
6-subst.indoles from 4-subst. nitro-anilines, 4-subst. indoles not possible(?) |
| x |
| | | #401 |
J. Org. Chem. |
48 |
2066 |
1983 |
S. Raucher |
4 |
Lil |
| 4 / 5-AcO / OH-, 6 / 7-OH-indoles |
4- / 5-OH-indole via Nemitzescu synth. via 2-NO2-6-/5-OH-benzaldehyde, acetoxy-2,beta-dinitrostyrene reduction with Fe / AcOH,
4-/5-Acetoxy-indole, 6-/7-OH-indole via 2-NO2-4-/3-OH-toluene, 2-NO2-4-/3-BzO-hippuric acid, 6- / 7-BzO-indole-carboxylate |
| x |
| | | #402 |
J. Chem. Soc. |
- |
1605 |
1948 |
R. J. S. Beer |
4 |
Lil |
| 5-MeO-indole, 5-MeO-tryptamine |
5-MeO-indole via phenylpyruvate, see ref. #110, 5-MeO-tryptamine via
5-MeO-indolyl-MgI with MeI, 5-MeO-indolyl-acetonitril with chloro acetonitril,
tryptamine with Na / EtOH |
| x |
| | | #403 |
Ann. |
513 |
1 |
1934 |
H. Wieland |
4 |
Lil |
| 5-EtO-/-MeO-indole, 5-EtO-Trp |
5-EtO-/-MeO-indole via phenylhydrazone, poor yields, 5-EtO-Trp via gramine /
acetamidomalonate |
| x |
| | | #404 |
J. Chem. Soc. |
- |
2462 |
1951 |
H. N. Rydon |
4 |
Lil |
| indolylacetic acid diethylamide |
diethy indolylacetamide from indol, MeI, and diethyl chloro-acetamide, yield 63% |
| | | | | #405 |
Arch. Pharm. |
275 |
506 |
1937 |
R. Wegler |
4 |
Lil |
| 7-Cl-4-OR-indoles |
4-OEtCl-7-Cl-indole from 4-Cl-3-NO2-phenol with 1. BrEtCl, yield 95% 2. vinyl-MgBr, yield 36%, 4-OR-3-COCF3-indole from indole with TFA, yields 90% |
| x |
| | | #531 |
J. Med. Chem. |
42 |
2007 |
1999 |
R. E. Mewshaw |
5 |
Lil |
| 7-R-indoles |
7-Me/Br/Cl/F-indole from 2-subst. nitrobenzenes with vinyl-MgBr, yields 42 - 67% |
| x |
| | | #532 |
Tet. Lett. |
30 |
2129 |
1989 |
G. Bartoli |
5 |
Lil |
| indole-1-protecting groups |
1-
tert
-butoxycarbonyl-, 1-phenoxycarbonyl-, 1-(trimethylsilylethoxy)carbonyl-,
1-benzyloxycarbonyl-indole |
| x |
| | | #553 |
Synth. |
- |
95 |
1992 |
A. C. Weedon |
5 |
Lil |
| | | | | | | | | | | | | | | |
tryptamine N-methylation |
METs |
MEAs from methylamides or formylamines with LiAlH4 and ethyl acetate |
x |
| | | | #46 |
Helv. Chim. Acta |
49 |
1199 |
1966 |
R. Stauffer |
1 |
Lil |
| N,N-dimethyltryptophan benzylester |
N,N-dimethyltryptophan benzylester from tryptophan benzylester with formaline,
acetic acid, and NaCNBH4, yield 17% |
| | | | | #151 |
J. Med. Chem. |
37 |
1269 |
1994 |
A. M. MacLeod |
1 |
Lil |
| N,N-dimethyltryptamines |
5-subst. N,N-dimethyltryptamines from tryptamines with formaline, acetic acid,
and NaCNBH4, yield 71% / 83%, p-CN-phenylhydrazine, Cl-butyraldehyde acetal reaction |
x |
| x |
| | #152 |
J. Med. Chem. |
37 |
3023 |
1994 |
J. L. Castro |
1 |
Lil |
| N,N-dimethyltryptamines |
5-subst. N,N-dimethyltryptamines from tryptamines with formaline, acetic acid,
and NaCNBH4, p-subst. phenylhydrazines, Cl-butyraldehyde acetal reaction |
x |
| x |
| | #153 |
J. Med. Chem. |
36 |
1529 |
1993 |
L. J. Street |
1 |
Lil |
| N,N-dimethyltryptamines |
5-subst. N,N-dimethyltryptamines from tryptamines with formaline, acetic acid,
and NaCNBH4, p-subst. phenylhydrazines, Cl-butyraldehyde acetal and
N,N-dimetylaminobutyraldehde acetal reaction |
x |
| x |
| | #154 |
J. Med. Chem. |
38 |
1799 |
1995 |
L. J. Street |
1 |
Lil |
| N,N-dimethyltryptamines |
5-subst. N,N-dimethyltryptamines from tryptamines with formaline, acetic acid,
and NaCNBH4, or from 1. benzaldehyde, NaCNBH3, 2. Me2SO4 / K2CO3, 3. H2, Pd/C. p-subst. phenylhydrazines, Cl-butyraldehyde acetal reactiOn |
x |
| x |
| | #155 |
J. Med. Chem. |
38 |
3566 |
1995 |
R. C. Glen |
1 |
Lil |
| methylamines |
methylamines from amines with formaline, NaCNBH4 in |
| x |
| | | #156 |
J. Org. Chem. |
37 |
1673 |
1972 |
R. F. Borch |
1 |
Lil |
| alkylamines |
alkylamines frOm aldehydes / ketOnes and amines with NaBH(OAc)3, alsO fOr acid sensitive grOups |
| x |
| | | #157 |
Tet. Lett. |
31 |
5595 |
1990 |
A. F. Abdel-Magid |
1 |
Lil |
| indoline sidereaction |
indolines from indoles with NaBH4 in acetic acid |
| x |
| | | #158 |
J. Am. Chem. Soc. |
96 |
7812 |
1974 |
G. W. Gribble |
1 |
Lil |
| NaBH4 in acetic acid |
sec. amine alkylation with NaBH4 in acetic acid |
| x |
| | | #159 |
Synth. |
- |
766 |
1978 |
G. W. Gribble |
1 |
Lil |
| NaBH4 in trifluoroacetic acid |
sec. amine alkylation with NaBH4 in trifluoroacetic acid |
| x |
| | | #160 |
Synth. |
- |
709 |
1987 |
G. W. Gribble |
1 |
Lil |
| N,N-dimethyl-indolylbicycloheptanamines |
N,N-dimethyl-indolylbicycloheptanamines from amines with formaline, acetic
acid, NaBHCN3, yield 83% - 90% |
x |
| | | | #161 |
Arch. Pharm. |
327 |
67 |
1994 |
K. Rehse |
1 |
Lil |
| tert. amines |
tert. amines from quart. amine iodides with LiAlH4 in THF, good yields |
| x |
| | | #162 |
J. Am. Chem. Soc. |
82 |
4651 |
1960 |
A. C. Cope |
1 |
Lil |
| 5-tBu- and 5-cyclopentyltryptamine |
5-alkyltryptamines as specific 5-HT1D agonists: N-propylation (nPrI: 3% sec., 75% tert.), N-methylation (DMS: 11%
tert., (BoC)2O / LiAlH4: 70%), tryptamines from hydrazines and phtalimidobutyraldehyde acetals, no 5-HT2 binding data |
x |
| x |
| | #163 |
J. Med. Chem. |
42 |
526 |
1999 |
Y.-C. Xu |
2 |
Lil |
| methylamines ? |
methylamines from amines with formaldehyde, Ti(OiPr)4, and NaBH4, high yields (4-dimethylamino-butyraldehyde diethylacetal from available
4-aminobutyraldehyde diethylacetal, yield 92%) |
| x |
| | » |
#56 |
Tet. Lett. |
35 |
2401 |
1994 |
S. Bhattacharyya |
1 |
Lil |
| methylamines |
methylamines from amines with NaBH4, ZnCl2, and paraformaldehyde im CHCl2, good yields |
| x |
| | | #203 |
Synth. Commun. |
25 |
2061 |
1995 |
S. Bhattacharyya |
2 |
Lil |
| 7-MeO-1-naphtyl-ethylamine, N-methylation |
7-MeO-1-naphtyl-ethylamine from 7-MeO-naphtyl-1-acetic acid, N-methylation via
trifluoroacetamide methylation with MeI, melatonine analogues |
x |
| | | » |
#321 |
J. Med. Chem. |
37 |
3231 |
1994 |
P. Depreux |
3 |
Lil |
| | | | | | | | | | | | | | | |
PTC N-alkylation |
2-COOR-indole 1-methylation, alkanoyl-indole reduction |
2-COOR-1-Me-indole from 2-COOR-indole with methyl-p-toluenesulfonate, NaOH,
tetrabutylammonium bromide in CH2Cl2, 3-alkyl-indoles from 3-alkanoylindoles with NaBH4 / BF3-Et2O |
| x |
| | | #320 |
J. Med. Chem. |
40 |
2694 |
1997 |
M. Lehr |
3 |
Lil |
| PTC indole-1-sulfonylation |
PTC indole-1-sulfonylation with TBA-HS, NaOH, and sulfonic acid chloride in H2O / benzene, yields > 85% |
| | | | | #548 |
Synth. |
- |
136 |
1979 |
V. O. Illi |
5 |
Lil |
| | | | | | | | | | | | | | | |
constrained tryptamines |
dihydropyrano constr. tryptamines |
dihydropyrano analogs of N-methyl-pyrrolidin-2-ylmethyl- and
N-methyl-pyrrolidin-3-yl-indoles |
x |
| | | | #164 |
Tet. Lett. |
35 |
45 |
1994 |
J. E. Macor |
1 |
Lil |
| dihydropyrano constr. tryptamines |
dihydropyrano analogs of (1-Me, N,N-di-Me-) tryptamines, rat 5-HT1A (8-OH-DPAT), bovine 1D (serotonin), rat 2A (ketanserin, DOI), pig 2C (mesulergine) receptor binding data, IP accumulation data, some compounds have
a higher activity than 5-HT |
x |
| x |
| | #326 |
J. Med. Chem. |
35 |
3625 |
1992 |
J. E. Macor |
3 |
Lil |
| 5-subst.N-Me-pyrrolidinylmethyl-indole |
5-subst. N-methyl-pyrrolidin-2-ylmethyl-indoles, 12-step synthesis |
x |
| | | | #165 |
Tet. Lett. |
33 |
8011 |
1992 |
J. E. Macor |
1 |
Lil |
| 5-amino N-Me-pyrrolidinylmethyl-indole |
N-methyl-pyrrolidin-2-ylmethyl-5-aminoindole with 2,5-dimethylpyrrole as amino
protecting group |
x |
| | | | #166 |
J. Org. Chem. |
59 |
7496 |
1994 |
J. E. Macor |
1 |
Lil |
| 5-MeO-constr. |
N-methyl-pyrrolidin-2-ylmethyl-5-MeO-indole, binding data and PI turnover /
ad.-cyclase test |
x |
| x |
| | #167 |
J. Med. Chem. |
35 |
4503 |
1992 |
J. E. Macor |
1 |
Lil |
| Z-Pro |
Z-Pro with benzyloxycarbonylchloride |
| x |
| | | #168 |
Ber. |
91 |
462 |
1958 |
W. Grassmann |
1 |
Lil |
| Z-Pro |
Z-amino acids with different reagents |
| x |
| | | #169 |
Synth. |
- |
958 |
1986 |
E. Wünsch |
1 |
Lil |
| Z-Pro |
Z-Pro with benzyloxycarbonylchloride |
| x |
| | | #170 |
J. Org. Chem. |
53 |
2861 |
1988 |
E. J. Corey |
1 |
Lil |
| Z-Pro |
Z-Pro with benzyloxycarbonylchloride |
| x |
| | | #171 |
J. Org. Chem. |
53 |
2861 |
1988 |
E. J. Corey |
1 |
Lil |
| Z-Pro |
Z-Pro with benzyloxycarbonylchloride |
| x |
| | | #172 |
J. Am. Chem. Soc. |
76 |
5552 |
1954 |
A. Berger |
1 |
Lil |
| RU-24969 derivative |
tetrahydropyrrolopyridone synth, 5-HT1A, 1B, 1C, 1D, and 2 binding data including (nor-) RU-24969, food intake test, ad.-cyclase test |
x |
| x |
x |
| #173 |
J. Med. Chem. |
33 |
2087 |
1990 |
J. E. Macor |
1 |
Lil |
| subst. 2-amino-cyclopentyl/hexylindol |
subst. 3-(2-amino-cyclopentyl / hexyl)-indoles via indolylmagnesiumbromide /
magnesium cuprate |
x |
| | | | #174 |
Tet. Lett. |
37 |
683 |
1996 |
J. Ezquerra |
1 |
Lil |
| N,N-dimethyl-indolylbicycloheptanamines |
(N,N-dialkyl-) indolylbicycloheptanamines receptor binding, low affinity 5-HT2 antagonists |
x |
| x |
| | #175 |
Arch. Pharm. |
326 |
893 |
1993 |
S. Elz |
1 |
Lil |
| 2-amino-indolyl-bicycloactane |
9 amino-indolyl-bicycloactanes, rat 5-HT2A (ketanserin) and 1A (8-OH-DPAT) binding data, weak ligands |
x |
| x |
| | #287 |
J. Med. Chem. |
33 |
386 |
1990 |
M. F. Schlecht |
3 |
Lil |
| 3-tetrahydropyridin-3-ylindoles |
5,N-subst. 3-tetrahydropyridin-3-ylindoles, 5-HT1A and 5-HT2A binding data |
x |
| x |
| | #176 |
Bioorg. Med. Chem. Lett |
5 |
2963 |
1995 |
T. Dahlgren |
1 |
Lil |
| different constr. subst. tryptamines |
(subst.) MTHPI, 3-tetrahydropyridin-3-ylindoles 5-HT1, 1A, 2 binding data |
? |
| x |
| | #177 |
Life Sci. |
41 |
1961 |
1987 |
E. W. Taylor |
1 |
Lil |
| imidazolylmethylindole |
imidazolylmethylindole from indolyl acetic acid and ethylendiamine |
x |
| | | | #178 |
Eur. J. Med. Chem. |
29 |
941 |
1994 |
M. Verma |
1 |
Lil |
| indolyl-cyclopropylamines |
5-MeO- / 5-F- / 4-MeO-trans-2-(indol-3-yl)cyclopropylamines, rat 5-HT1A, hum. 5-HT2A, 2B, 2C binding data |
x |
| x |
| | #204 |
J. Med. Chem. |
41 |
4995 |
1998 |
S. Vangveravong |
2 |
Lil |
| 5-triazolo-N-Me-piperid-3-yl-indole and -DMT |
5-triazolo-N-Me-piperid-3-yl-indole and 5-triazolo-DMT through phenylhydrazine
/ aldehyde route, binding data for many 5-HT-receptors, poor binding to 5-HT2 |
x |
| x |
| » |
#245 |
Bioorg. Med. Chem. Lett. |
6 |
1825 |
1996 |
F. Sternfeld |
3 |
Lil |
| 3-(pyrrrolidin-3-yl)indoles |
N-, 5-, 6-subst. 3-(pyrrrolidin-3-yl)indoles from 1. indoles and succinimides
in AcOH 2. LiAlH4 reduction |
x |
| | | | #309 |
Synthesis |
- |
443 |
1997 |
J. E. Macor |
3 |
Lil |
| pyrrrolidinyl-indole, N-Me-pyrrolidinylmethyl-indole |
5-nitropyridylamino subst. N-methyl-pyrrolidin-2-ylmethyl- and
N-methyl-pyrrolidin-3-yl-indoles, 5-HT1A and 1D binding and activity (AC inhibition) data |
x |
| x |
| | #310 |
J. Med. Chem. |
37 |
2509 |
1994 |
J. E. Macor |
3 |
Lil |
| methylamino-cyclohexyl/cyclopentyl-indoles |
(N-Me-) 3-(2-methylamino-cyclohexyl/cyclopentyl)-5-MeO-indoles, no binding to
5-HT receptors detectable |
x |
| | | | #312 |
Heterocycles |
31 |
1497 |
1990 |
J. E. Macor |
3 |
Lil |
| 3-piperidylmethyl-indoles |
5-OH-3-piperidymethyl-lindoles from indole-MgBr and chloromethylpyridine (in a
weakly polar solvent for 3-specifity), pyridine-N methylation for N-methyl
derivatives, an catalytic hydrogenation |
x |
| | | | #313 |
Arch. Pharm. |
308 |
209 |
1975 |
E. Friderichs |
3 |
Lil |
| 3-piperidylindoles |
5-OH-3-piperidyl-indoles via 3-pyridylindoles (via Fischer indole synthesis,
method of ref. #306), pyridine-N methylation for N-methyl derivatives, NaBH4 reduction to tetrahydropyridin, and catalytic hydrogenation |
x |
| | | | #314 |
Arch. Pharm. |
308 |
663 |
1975 |
E. Friderichs |
3 |
Lil |
| 5,N-subst. alpha-4 methylene bridged tryptamines |
5, N-subst. alpha/4 methylene bridged tryptamines, rat 5-HT1 (5-HT) and 5-HT2 (spiperone) binding data, some have good 5-HT2 binding affinities (antagonist labeled!) |
x |
| x |
x |
| #334 |
J. Med. Chem. |
31 |
1746 |
1988 |
M. E. Flaugh |
3 |
Lil |
| amino-carboxamido-tetrahydrocarbazole |
3-amino-6-carboxamido-1,2,3,4-tetrahydrocarbazole, 5-HT1A, 2C, 1D, and 2A receptor binding data |
x |
| x |
| | #336 |
J. Med. Chem. |
36 |
1918 |
1993 |
F. D. King |
3 |
Lil |
| dihydropyrano constr. DMT |
dihydropyrano analogs of N,N-di-Me-tryptamine synthesis |
x |
| | | | #399 |
Tet. Lett. |
48 |
1039 |
1992 |
J. E. Macor |
4 |
Lil |
| 2-alpha- and 2,beta-ethylen brigded 5-MeO-T |
2-alpha- and 2,beta-ethylene and -propylene bridged 5-MeO-tryptamines |
x |
| | | | #406 |
J. Med. Chem. |
41 |
451 |
1998 |
D. J. Davies |
4 |
Lil |
| 5-subst. 3-piperidylindole-2-COOR and DMT-2-COOR |
5-subst. 3-piperidylindoles-2-COOR and DMT-2-COOR from anilines and subst.
acetoacetate from acetoacetate, NaOEt, and dimethylaminopropyl chloride |
| x |
| | | #475 |
J. Med. Chem. |
40 |
2347 |
1997 |
G. P. Moloney |
4 |
Lil |
| peduncularine |
peduncularine (indolylmethyl-azabicycloocten) synthesis via phenylhydrazine and
alkyl acetal in 4% H2SO4, yield 32% |
| | | | | #554 |
J. Am. Chem. Soc. |
111 |
2588 |
1989 |
W. J. Klaver |
5 |
Lil |
| | | | | | | | | | | | | | | |
open-ring tryptamines |
subst. 2-(3-amino-1-oxopropyl)-anilines |
subst. 2-(3-amino-1-oxopropyl)-anilines, rat fundus strip data, all substances
are agonists |
x |
| x |
| | #179 |
Drug Res. |
33 |
515 |
1983 |
W. Back |
1 |
Lil |
| 5-MeO-2-(3-dimethylamino-1-oxo-propyl)-aniline |
5-MeO-2-(3-dimethylamino-1-oxopropyl)-aniline, phenylpiperazine and
bezoylpiperazine subst. amphetamine analogs, rat 5-HT1 (5-HT) and 2 (ketanserin) binding data, rat drug discrimination data (TFMPP, DOM), all have
higher affinity for 5-HT1 (aniline 24x) |
x |
| x |
x |
» |
#327 |
J. Med. Chem. |
29 |
630 |
1986 |
R. A. Lyon |
3 |
Lil |
| | | | | | | | | | | | | | | |
reductions / hydrogenations |
sodium dithionite |
reductive alkylation with sodium dithionite (Na2S2O4), yield 68% (dicyclohexylamine) |
| x |
| | | #180 |
Aust. J. Chem. |
32 |
201 |
1979 |
P. M. Pojer |
1 |
Lil |
| Pd/C, formic acid |
catalytic hydrogenation with in sity H2 generation from formic acid (1-azido-3-indolyl-aceton), indole grignard
reaction |
| x |
| | | #181 |
J. Het. Chem. |
25 |
469 |
1988 |
J. P. Sanchez |
1 |
Lil |
| nitropropene reduction |
NaBH4 / NiCl2 reduction of 1-nitrocyclohexene to cyclohexylamine, isolated yield 66%,
rection yield maybe higher |
| x |
| | | #182 |
Tet. Lett. |
26 |
6413 |
1985 |
J. O. Osby |
1 |
Lil |
| 2,4,5-triMeO-PEA, electrolytic reduction |
2,4,5-triMeO-PEA via different old routes, electrolytic reduction, self
experiment |
x |
| | | » |
#13 |
Recl. Trav. Chim. |
50 |
291 |
1931 |
M. P. J. M. Jansen |
2 |
Lili |
| nitrostyrene Zn-Hg / HCl reduction |
2-EtO/PrO-3-MeO-nitrostyrene reduction to PEA with Zn-Hg / HCl, yield 60% /
52%, 3,4-methylendioxy-benzylcyanide reduction with H2 / EtOH / Raney-Ni / NH3, yield 58% |
| x |
| | | #534 |
Bull. Soc. Chim. |
? |
231 |
1960 |
R. Delaby |
5 |
Lil |
| nitrostyrene Zn-Hg / HCl reduction |
3-Br-4-OCO2Et-(5MeO-)nitrostyrene reduction to 3-Br-4-OCO2Et-(5MeO-)PEA with Zn-Hg / HCl, yield 63% (65%) |
| x |
| | | #522 |
Arch. Pharm. |
322 |
477 |
1989 |
P. Pachaly |
5 |
Lil |
| nitrostyrene NaBH4 / Me3SiCl reduction |
2,3,4-trimethoxy-nitrostyrene reduction to PEA with NaBH4 / Me3SiCl, aminoalcohols from AA, prim., sec., tert. amines from amides, amine from
cyano, yields > 90% |
| x |
| | | #523 |
Angew. Chem. |
101 |
220 |
1989 |
A. Giannis |
5 |
Lil |
| nitrostyrene electrolytical reduction |
2-Br-3,4-diMeO-nitrostyrene electrolytical reduction to 2-Br-3,4-diMeO-PEA,
yield 50%, nitrostyrene from aldehyde with nitromethane |
| x |
| | | #524 |
Chem. Pharm. Bull. |
11 |
1491 |
1963 |
K. Bessho |
5 |
Lil |
| nitroalkene reductions to amines and hydroxylamines |
nitroalkenes (incl. 3,4-diMeO-phenyl-nitropropene) reductions to amines with BH3-THF / cat. NaBH4 in THF for 6 d, yields 85 - 91%, with NaBH4 / BF3-Et2O in THF, yields 74 - 79%, reductions to hydroxylamines with BH3-THF / cat. NaBH4 or NaBH4 / BF3-Et2O, yields 74 - 79%, reductions to nitroalkanes |
| x |
| | | #525 |
Tet. |
46 |
7443 |
1990 |
G. W. Kabalka |
5 |
Lil |
| nitroalkene reductions to amines |
nitroalkenes (incl. 3,4-diMeO-phenyl-nitropropene) reductions to amines with BH3-THF / cat. NaBH4 in THF for 6 d, yields 85 - 91% |
| x |
| | | #526 |
Synth. Comm. |
14 |
1099 |
1984 |
M.
S.
Mourad |
5 |
Lil |
| nitroalkene reductions to nitroalkanes |
nitroalkenes (incl. 3,4-diMeO-phenyl-nitropropene) reductions to nitroalkanes
with trialkyl borohydrides, yields 65 - 81% |
| x |
| | | #527 |
Synth. Comm. |
14 |
1093 |
1984 |
R.
S.
Varma |
5 |
Lil |
| nitrostyrene reduction with H2 / Pd / AcOH / H2SO4 |
3,4-methylenedioxy-nitrostyrene reduction to PEA with H2 / Pd / AcOH / H2SO4, yield 93% |
| x |
| | | #550 |
Ber. |
68 |
1579 |
1935 |
O. Schales |
5 |
Lil |
| nitrostyrene reduction with H2 / Pd / AcOH / H2SO4 |
2-OH-, 3-OH-, 3-MeO-4-OH-, and 4-OH-nitrostyrenes from benzaldehydes and
reduction to PEA with H2 / Pd / AcOH / H2SO4, yields 67 - 85% |
| x |
| | | #551 |
Ber. |
71 |
2154 |
1938 |
G. Hahn |
5 |
Lil |
| nitrostyrene reduction with Zn-Hg / HCl |
3,4-methylenedioxy-5-Br- and 3-MeO-4-EtOCO2-nitrostyrene reduction to PEA with Zn-Hg / HCl / EtOH, yields 81% and 56% |
| x |
| | | #552 |
Chem. Pharm. Bull. |
16 |
217 |
1968 |
M. Tomita |
5 |
Lil |
| nitrobenzene reduction with SnCl2 |
subst. nitrobenzene reduction to anilines with SnCl2, yields > 91%, erratum: #542 |
| | | | | #541 |
Tet. Lett. |
25 |
839 |
1984 |
F. D. Bellamy |
5 |
Lil |
| nitrobenzene reduction with SnCl2 |
erratum to #541 |
| | | | | #542 |
Tet. Lett. |
26 |
1362 |
1985 |
F. D. Bellamy |
5 |
Lil |
| red. alkylation with NaBH4 in H2O |
various red. alkylations of acetaldehyde, benzaldehyde, acetone, and
cyclohexanone with lysine esters, anilines, and alkylamines with NaBH4 in aqueous solution |
| x |
| | | #549 |
J. Org.Chem? |
28 |
3259 |
1963 |
K. A. Schellenberg |
5 |
Lil |
| | | | | | | | | | | | | | | |
N,N-dimethyl-Trp |
bromomalonates |
bromomalonates and bromomethylmalonates with CuBr2 |
| x |
| | | #183 |
Chem. Lett. |
- |
1091 |
1998 |
Y. Suzuki |
1 |
Lil |
| bromomalonates |
bromomalonates from malonic acid with 1. alcohol / HCl gas 2. Br2, yield 86% |
| x |
| | | #184 |
J. Org. Chem. USSR (Engl.Transl.) |
30 |
1042 |
1994 |
P. M. Kochergin |
2 |
Lil |
| dimethylamino-malonate |
ethyl dimethylamino-malonate from dimethylamine in EtOH and ethyl bromomalonate
(Org. Synth. Coll. Vol. 1, 245 1941 Palmer) |
| x |
| | | #185 |
J. Chem. Soc. |
- |
547 |
1949 |
E. R. H. Jones |
2 |
Lil |
| dimethylamino-malonate |
methyl dimethylamino-malonate from dimethylamine in MeOH and methyl
bromomalonate, yield 76% |
| x |
| | | #186 |
Coll. Czech. Chem. Comm. |
45 |
92 |
1980 |
V. Král |
2 |
Lil |
| dipropylamino-malonate |
ethyl dipropylamino-malonate from dipropylamine and ethyl bromomalonate in THF,
yield 85% |
| x |
| | | #187 |
J. Med. Chem. |
35 |
1076 |
1992 |
M. W. Moon |
2 |
Lil |
| (5-OH)-N,N-dimethyl-Trp |
(5-OH)-N,N-dimethyl-Trp from gramines and ethyl dimethylamino-malonate with 1.
NaOH, benzene 2. Ba(OH)2, MeOH 3. H2O, Na2SO4 |
| x |
| | | #188 |
Ann. Chem. (Rome) |
48 |
1037 |
1958 |
S. Corsano |
2 |
Lil |
| | | | | | | | | | | | | | | |
N-terminal substitutions |
2-CB and 5-MeO-T derivatives |
38 mainly N-substituted-benzyl 2-CB and 5-MeO-T derivatives, hum. 5-HT2A (ketanserin), 2A (DOI), and rat 2C binding data, some seem to be potent agonists |
x |
| x |
| | #190 |
J. Med. Chem. |
37 |
1929 |
1994 |
R. A. Glennon |
2 |
Lil |
| 5-MeO-N-Me-N-indolylmethyl-tryptamine |
5-MeO-N-Me-N-indolylmethyl-tryptamine isolation from
Antirhea
lucida
|
| | | | | #540 |
Planta Med. |
61 |
569 |
1995 |
B. Weniger |
5 |
Lil |
| | | | | | | | | | | | | | | |
QSAR |
hallucinogenic PEA QSAR |
49 2,4,5- and 3,4,5 subst. PEA in a (MTD-) QSAR study |
| | | | | #191 |
Quant. Struct.-Act. Relat. |
16 |
459 |
1997 |
M. Mracec |
2 |
Lil |
| hallucinogenic PEA and tryptamines QSAR |
66 subst. PEA and tryptamines in a CoMFA-QSAR study |
| | | | | #192 |
Quant. Struct.-Act. Relat. |
16 |
447 |
1997 |
G. Beuerle |
2 |
Lil |
| hallucinogenic PEA QSAR |
92 subst. PEA in a QSAR study |
| | | | | #274 |
J. Med. Chem. |
41 |
3845 |
1998 |
B. W. Clare |
3 |
Lil |
| 5-HT reuptake inhibitor pharmacophore |
5-HT reuptake inhibitor pharmacophoric model |
| | | | | #429 |
Pharm. Acta Helv. |
68 |
235 |
1994 |
A. Rupp |
4 |
Lil |
| | | | | | | | | | | | | | | |
various reactions |
Arylbromide methoxy substitution |
Cu(I) / ester catalyzed MeO-benzenes from Br-benzenes and MeONa |
| x |
| | | #193 |
Tet. Lett. |
34 |
1007 |
1993 |
P. Capdevielle |
2 |
Lil |
| N-methyl-N-formyl-1-Cl-isopropylamine |
N-methyl-N-formyl-1-Cl-isopropylamine from N-formyl-alanine with 1. LiAlH4 2. formamide 3. thionyl chloride |
| x |
| | | #199 |
J. Chem. Soc. |
- |
858 |
1957 |
A. H. Beckett |
2 |
Lil |
| methylendioxybenzenes |
methylendioxybenzenes from catechols and DCM or CH2BrCl with CsCO3 in DMF or acetonitrile, yields > 86% |
| x |
| | | #194 |
Tet. Lett. |
32 |
2461 |
1991 |
R. E. Zelle |
2 |
Lil |
| 2-OH-4,5-diMeO-benzaldehyde |
2-OH-4,5-diMeO-benzaldehyde from 3,4-diMeO-benzaldehyde with m-Cl-perbenzoic
acid (MCPBA) |
| x |
| | | #195 |
J. Chem. Soc. Perk. I |
- |
1435 |
1996 |
K. Chiba |
2 |
Lil |
| N-alkyl-N-acetyl-anilines |
N-alkyl-N-acetyl-anilines from N-acetyl-anilines, alkylating agent, and PTC
(TEBA), yields 82% - 95% |
| x |
| | | #202 |
Synth. |
- |
113 |
1976 |
R. Brehme |
2 |
Lil |
| | | | | | | | | | | | | | | |
indole oxidation |
5-oR-tryptamines and -tryptophanes |
5-MeO and 5-OH-tryptamines and -tryptophans from tryptamine and tryptophan in
good yields |
x |
| | | | #196 |
Chem. Pharm. Bull. |
32 |
2544 |
1984 |
M. Taniguchi |
2 |
Lil |
| 1-OH-tryptamine-amides |
1-OH-tryptamine-amides and 1-OH-DMT from tryptamine-amides and DMT with 1.
triethylsilane in CF3COOH, yield 92% 2. Na2WO4*2H2O, yield 55% - 72%, no details given |
| x |
| | | #200 |
Het. |
40 |
119 |
1995 |
M. Somei |
2 |
Lil |
| 1-OH-tryptamine-amides |
5-MeO-N-acetyl-tryptophan-methylester from 1-OH-N-acetyl-tryptophan-methylester
with H2SO4 / MeOH, yield 71%, no details given |
| x |
| | | #201 |
Het. |
36 |
1859 |
1993 |
M. Somei |
2 |
Lil |
| | | | | | | | | | | | | | | |
indazoles |
tryptamine indazole analog |
tryptamine indazole analog, lengthly synthesis, pharmacological activities
compared to tryptamine |
x |
| x |
| | #218 |
J. Am. Chem. Soc. |
79 |
5242 |
1957 |
C. Ainsworth |
2 |
Lil |
| 5-HT indazole analog |
5-HT indazole analog, lengthly synthesis, activities compared to 5-HT: on rat
uterus 50%, guinea pig ileum 80% |
x |
| x |
| | #213 |
J. Am. Chem. Soc. |
79 |
5245 |
1957 |
C. Ainsworth |
2 |
Lil |
| tryptamine / 5-HT indazole analogs |
tryptamine / 5-HT indazole analogs pharmacological data (rat uterus, rat blood
pressure), synthesis of 1- and 2-sidechain analogs |
x |
| x |
| | #224 |
J. Am. Chem. Soc. |
80 |
965 |
1958 |
C. Ainsworth |
2 |
Lil |
| indazole-3-acetic acid |
indazole-3-acetic acid from 2-NO2-cinnamic acid (Fischer indazole synthesis), references |
| x |
| | | #223 |
J. Am. Chem. Soc. |
80 |
967 |
1958 |
C. Ainsworth |
2 |
Lil |
| 4-alkylO- / 4-OH-3-Me-indazoles |
4-alkylO- / 4-OH-3-Me-indazoles from 2,6-alkylO-/OH-acetophenone with 1.
hydrazine, AcOH, 110°C 2. polyphosphoric acid, 115°C, yields 60% -
80% (4-OH: 34%), cool synthesis! |
| x |
| | | #205 |
J. Chem. Soc. Perk. I |
- |
1279 |
1993 |
Z. Zhenqi |
2 |
Lil |
| 2,6-dihydroxy-acetophenones |
2,6-dihydroxy-acetophenone from 1,3-hydroxy-benzene and acetoacetate with 1. H2SO4 2. Ac2O 3. AlCl3, 170°C 4. NaOH, H2O, overall yield > 40% |
| x |
| | | #206 |
Org. Synth. Coll. Vol. |
3 |
281 |
1955 |
A. Russell |
2 |
Lil |
| subst. dimethylamino-propiophenone |
2,4-dimethoxy-dimethylamino-propiophenone from 2,4-dimethoxy-acetophenone with
dimethylamine-HCl, paraformaldehyde, and HCl in EtOH (Mannich reaction) |
| x |
| | | #207 |
J. Chem. Soc. Perk. I |
- |
471 |
1981 |
R. H. Carter |
2 |
Lil |
| subst. dialkylamino-propiophenones |
2-OH-(5-Me-)-dialkylamino-propiophenone from 2-OH-(5-Me-)acetophenone with
dialkylamine, formaldehyde 30%, and HCl gas in EtOH (Mannich reaction), yield
~60% |
| x |
| | | #208 |
Synth. |
- |
830 |
1988 |
S. J. Joglekar |
2 |
Lil |
| subst. dialkylamino-propiophenones |
2,4-dimethoxy-(6-MeO-)-dialkylamino-propiophenone from
2,4-dimethoxy-(6-MeO-)acetophenone with dialkylamine, formaldehyde, and HCl in
EtOH (Mannich reaction) (patent: Fr 1,492,256) |
| x |
| | | #209 |
CA |
69 |
35958v |
1968 |
S.O.R.I. |
2 |
Lil |
| subst. dimethylamino-propiophenones |
subst. dimethylamino-propiophenones from acetophenone with dimethylamine-HCl,
formaldehyde, and HCl in EtOH (Mannich reaction) |
| x |
| | | #210 |
Eur. J. Med. Chem. |
22 |
545 |
1987 |
J. R. Dimmock |
2 |
Lil |
| subst. dimethylamino-propiophenones |
2,4-dihydroxy-dimethylamino-propiophenones from 2,4-dihydroxy-acetophenone with
dimethylamine-HCl, paraformaldehyde, and HCl in EtOH (Mannich reaction), yield
~9% |
| x |
| | | #211 |
Arch. Pharm. |
299 |
552? |
1966 |
?. Zymalkowski |
2 |
Lil |
| subst. dimethylamino-propiophenone |
pharmacology of subst. dimethylamino-propiophenones, synthesis: reference #210 |
| x |
| | | #212 |
Pharmazie |
46 |
538 |
1991 |
J. R. Dimmock |
2 |
Lil |
| 2,6-dihydroxy-alkanoylbenzenes |
2,6-dihydroxy-alkanoylbenzenes from 2,6-dimethoxy-benzonitriles with 1.
AlkylMgCl 2. AlCl3, yield ~70% |
| x |
| | | #214 |
J. Am. Chem. Soc. |
64 |
1313 |
1942 |
A. Russell |
2 |
Lil |
| 2,6-dimethoxy-acetophenone |
2,6-dimethoxy-propiophenone from 1,3-dimethoxybenzene with 1. PhLi 2.
acetylchloride, yield 14% (intermediate) |
| x |
| | | #215 |
Ann. |
709 |
63 |
1967 |
K.-H. Boltze |
2 |
Lil |
| 2-MeO-dimethylamino-propiophenone |
2-MeO-dimethylamino-propiophenone from 2-MeO-acetophenone with
dimethylamine-HCl, paraformaldehyde, and HCl in EtOH (Mannich reaction), yield
~70% |
| x |
| | | #216 |
Tet. |
23 |
4729 |
1967 |
G. L. Buchanan |
2 |
Lil |
| 2,6-dihydroxy-acetophenone |
2,6-dihydroxy-acetophenone, synthesis like reference #206 |
| x |
| | | #217 |
J. Org. Chem. |
32 |
2881 |
1967 |
E. Marcus |
2 |
Lil |
| piperazine-indazol analogs of tryptamine |
phenylpiperazine-indazol analogs of tryptamine via 2-NO2-cinnamic acid, 2-NH2-cinnamic acid (H2, Raney Ni, 45 psi), indazole-3-acetic acid (HCl, NaNO2, Na2SO3), phenylpiperazinyl-ethyl-indazol (iso-BuO2CCl, NEt3, phenylpiperazine) (patent US 3,488,353) |
| x |
| | | #219 |
CA |
72 |
66979u |
1970 |
S. Archer |
2 |
Lil |
| piperazine-indazol analogs of tryptamine |
phenylpiperazine-indazol analogs of tryptamine via 5-MeO-2-NO2-benzaldehyde, 5-MeO-2-NO2-cinnamic acid, 2-NH2-cinnamic acid (conc. NH3, FeSO4), indazole-3-acetic acid (HCl, NaNO2, Na2SO3), (patent Fr. 1,434,479) |
| x |
| | | #220 |
CA |
65 |
20150c-g |
1966 |
A. Hofmann |
2 |
Lil |
| indazole-3-aldehyde |
indazole-3-aldehyde from indazole-3-COOH with hydrazine |
| x |
| | | #221 |
J. Chem. Soc. |
- |
5901 |
1963 |
G. R. Bedford |
2 |
Lil |
| piperazine-indazol analog of tryptamine |
phenylpiperazine-indazol analog of tryptamine (patent US 3,362,956) |
| x |
| | | #222 |
CA |
69 |
10467w |
1968 |
S. Archer |
2 |
Lil |
| 2,6-dimethoxy-acetophenone |
2,6-dimethoxy-propiophenone from 1,3-dimethoxybenzene with 1.BuLi 2. ethyl
acetate, yield 60% |
| x |
| | | #225 |
J. Org. Chem. |
39 |
3559 |
1974 |
R. Levine |
2 |
Lil |
| 2,6-dimethoxy-valerophenone |
2,6-dimethoxy-iso-valerophenone from 2,6-dimethoxy-benzonitrile with iso-BuMgBr |
| x |
| | | #226 |
J. Chem. Soc. |
- |
1163 |
1933 |
A. Robertson |
2 |
Lil |
| 2,6-dihydroxy-alkanoylbenzenes |
2,6-dihydroxy-alkanoylbenzenes, synthesis like reference #206 |
| x |
| | | #227 |
J. Med. Chem. |
20 |
1194 |
1977 |
A. Bobik |
2 |
Lil |
| 3-C-glycosyl-indazoles |
3-C-glycosyl-indazoles from diazaketoses and anthranilic acids |
| x |
| | | #228 |
J. Het. Chem. |
13 |
1241 |
1976 |
E. García-Abbad |
2 |
Lil |
| 3-alkyl-indazoles |
3-alkyl-indazoles via 2-amino-benzonitroiles, 2-amino-alkanoylbenzens
(alkylMgX), 3-alkyl-indazoles (Fischer indazole synthesis with SO2 / H20) |
| x |
| | | #229 |
Pharmazie |
31 |
534 |
1976 |
E. Hannig |
2 |
Lil |
| 3-Me-indazole |
3-Met-indazole from 2-F-acetophenone or 2-NH2-acetophenone |
| x |
| | | #230 |
J. Med. Chem. |
40 |
2708? |
1997 |
?. Henke |
2 |
Lil |
| | | | | | | | | | | | | | | |
7-subst. tryptamines |
7-Me-tryptamines |
7-Me- / 5-Me- / 4-F-7-Me-tryptamine through Abramovitch / Shapiro route |
x |
| | | | #231 |
J. Am. Chem. Soc. |
70 |
4699 |
1948 |
Z. Pelchowicz |
3 |
Lil |
| 7-Me-N,N-dimethyltryptamine |
7-Me-N,N-dimethyltryptamine Speeter / Anthony synthesis, selective synaptosomal
5-HT uptake inhibitor, rat behavioural data, synaptosomal uptake data |
x |
| x |
x |
| #232 |
Res. Comm. Chem. Path. Pharmacol. |
19 |
161 |
1978 |
R. A. Glennon |
3 |
Lil |
| 4-OH-7-Me-indole |
4-OH-7-Me-indole via 2-NO2-4-BzO-toluene, 2-NH2-4-BzO-toluene (H2, Raney Ni, yield 84%), N-(5-BzO-2-Me-phenyl)-aminoacetaldehyde acetal (NaNH2, chloroacetaldehyde acetal, yield 70%), 4-BzO-7-Me-indole (aniline-HCl, heat,
yield 6% (sic)) |
| x |
| | | #233 |
Helv. Chim. Acta |
51 |
1203 |
1968 |
F. Troxler |
3 |
Lil |
| 7-Me-tryptamines |
7-Me-tryptamines from 2-Me-hydrazine and aminobutyraldehyde diethylacetal with
ZnCl2 |
x |
| | | | #234 |
Monaths. Chem. |
81 |
404 |
1950 |
K. Eiter |
3 |
Lil |
| 7-Me-5-MeO-N,N-dimethyltryptamine |
7-Me-5-MeO-N,N-dimethyltryptamine from dimethylpyrone, Leimgruber / Batcho
reaction, Speeter / Anthony reaction |
x |
| | | | #235 |
J. Het. Chem. |
13 |
749 |
1976 |
F. Benington |
3 |
Lil |
| 7-Br-4-MeO-N,N-dimethyltryptamines |
7-Br-4-MeO-N,N-dimethyltryptamine via 2-MeO-5-Br-benzaldehyde,
4-MeO-7-Br-indole (1. ethyl azidoacetate 2. heat, catalyst), Speeter / Anthony
reaction |
x |
| | | | #236 |
J. Het. Chem. |
18 |
1373 |
1981 |
S. Samreth |
3 |
Lil |
| 7-Br- and 5-MeO-DMT, 5-HT2 binding |
21 subst. tryptamines incl. 7-Br- and 5-MeO-DMT, 4 subst. PIA, rat 5-HT2 (ketanserin, DOB) binding data |
| | x |
| » |
#244 |
Eur. J. Pharmacol. |
145 |
291 |
1988 |
R. A. Lyon |
3 |
Lil |
| 1- and 7-alkyl subst. alpha-Me-tryptamines |
9 DOM alpha, N-analogues, 7 tryptamines, isomers, rat drug discrimination data
(DOM) |
| | | x |
» |
#258 |
Biochem. Pharmacol. |
32 |
1267 |
1983 |
R. A. Glennon |
3 |
Lil |
| 8 subst. DMT |
8 subst. DMT incl. 7-Me-, 7-Et-, 7-Br-, 5-MeO-7-Me-, 6-Me-, 5-MeO-6-Me-DMT, rat
stomach fundus strip data, rat drug discrimination data, comparison to
5-MeO-DMT (all are weaker or different) and DMT (some are stronger) |
x |
| x |
x |
| #324 |
J. Med. Chem. |
23 |
1222 |
1980 |
R. A. Glennon |
3 |
Lil |
| 12 tryptamines incl. 7-subst., 2 PEA |
12 tryptamines incl. 7-subst., 2 PEA, rat drug discrimination, rat stomach
fundus strip data |
| | x |
x |
» |
#325 |
Psychopharmacology |
68 |
155 |
1980 |
R. A. Glennon |
3 |
Lil |
| | | | | | | | | | | | | | | |
binding data |
31 PEA, 5-HT2A, 2C binding |
31 ring substituted PEA and PIA, rat 5-HT2A (ketanserin) and 2C (mesulergine) binding data |
x |
| x |
| | #243 |
J. Med. Chem. |
35 |
734 |
1992 |
R. A. Glennon |
3 |
Lil |
| 21 tryptamines, 4 PIA, 5-HT2 binding |
21 1-, 4-, 5-, 6-, 7-, alpha-, and N-subst. tryptamines, 4-iso-tryptamine, and
4 subst. PIA, rat 5-HT2 (ketanserin, DOB) binding data, low / high aff. binding data |
| | x |
| | #244 |
Eur. J. Pharmacol. |
145 |
291 |
1988 |
R. A. Lyon |
3 |
Lil |
| rat vs. hum. 5-HT2 binding |
13 different tryptamines and PIA, rat and hum. 5-HT2 (ketanserin) binding data, autoradiography |
| | x |
| | #246 |
Psychopharmacol. |
98 |
495 |
1989 |
B. Sadzot |
3 |
Lil |
| 17 PIA |
17 PIA, rat 5-HT2 (ketanserin) and 5-HT1 (LSD) binding data, low / high aff. binding data |
| | x |
| | #247 |
Eur. J. Pharmacol. |
102 |
23 |
1984 |
M. Shannon |
3 |
Lil |
| N-Me-DOB derivatives |
sec., tert., and quart. N-Me-DOB derivatives, rat. 5-HT2 (ketanserin, DOB) binding data, rat drug discrimination data (DOB) |
x |
| x |
x |
| #248 |
J. Med. Chem. |
30 |
930 |
1987 |
R. A. Glennon |
3 |
Lil |
| 5-MeO/OH-N,N-di-Pr/Me/H-tryptamines |
5-MeO/OH-N,N-di-Pr/Me/H-tryptamines, rat 5-HT1A (8-OH-DPAT), 1B (serotonin), 2 (ketanserin, DOB) binding data, rat drug discrimination data (8-OH-DPAT, DOM) |
x |
| x |
x |
| #249 |
J. Med. Chem. |
31 |
867 |
1988 |
R. A. Glennon |
3 |
Lil |
| N-methyl-N-isopropyl-tryptamines |
8 indole-subst. N-methyl-N-isopropyl-tryptamines, hum. activity data |
x |
| x |
x |
| #250 |
J. Med. Chem. |
28 |
892 |
1985 |
D. B. Repke |
3 |
Lil |
| (±)/(+)/(-)-5-MeO-alpha-Me-tryptamine |
(±)/(+)/(-)-5-MeO-alpha-Me-tryptamine and 5-MeO-DMT, rat drug
discrimination data (DOM) |
| | | x |
| #251 |
Biol. Psychiatry |
18 |
493 |
1983 |
R. A. Glennon |
3 |
Lil |
| 13 DOB analogues |
13 DOB analogues, rat 5-HT1 (serotonin) and 2 (ketanserin) binding data, rat drug discrimination data (DOM) |
x |
| x |
x |
| #252 |
J. Med. Chem. |
29 |
194 |
1986 |
R. A. Glennon |
3 |
Lil |
| 5-HT1A binding review |
5-HT1A binding review, many classes of compounds incl. subst. tryptamines and MTHPI |
| | x |
| | #253 |
Pharmacol. Biochem. Behav. |
40 |
1041 |
1991 |
D. L. Nelson |
3 |
Lil |
| 4-(2-butyl)/(2-Me-propyl-2,5-DMA |
4-(2-butyl)/(2-Me-propyl-2,5-DMA, rat drug dicrimination data (LSD) |
| | | x |
| #254 |
J. Med. Chem. |
27 |
788 |
1984 |
R. A. Oberlender |
3 |
Lil |
| 10 PIA, DMT, 5-MeO-DMT, 7-Me-DMT |
10 PIA, DMT, 5-MeO-DMT, 7-Me-DMT, rat stomach fundus strip data |
| | x |
| | #255 |
J. Med. Chem. |
21 |
822 |
1978 |
R. A. Glennon |
3 |
Lil |
| quipazines, naphtylpiperazines |
quipazines, naphtylpiperazines, rat 5-HT1 (serotonin) and 2 (ketanserin) binding data, rat drug discrimination data (DOM, TFMPP) |
x |
| x |
x |
| #256 |
J. Med. Chem. |
29 |
2375 |
1986 |
R. A. Glennon |
3 |
Lil |
| 1- and 7-alkyl subst. alpha-Me-tryptamines |
1-Pr-/Am-/oct-/Bz- and 7-Pr-/Am-(alpha-Me)-tryptamines, rat 5-HT1 (serotonin) and 2 (ketanserin, DOB) binding data |
x |
| x |
| | #257 |
J. Med. Chem. |
33 |
2777 |
1990 |
R. A. Glennon |
3 |
Lil |
| 9 DOM analogues, 7 tryptamines |
9 DOM alpha, N-analogues, 7 tryptamines, isomers, rat drug discrimination data
(DOM) |
| | | x |
| #258 |
Biochem. Pharmacol. |
32 |
1267 |
1983 |
R. A. Glennon |
3 |
Lil |
| 5-MeO-alpha-Me-tryptamine |
5-MeO-alpha-Me-tryptamine, hum. activity data |
| | | x |
| #259 |
Biol. Psychiatry |
15 |
349 |
1980 |
R. E. Kantor |
3 |
Lil |
| 45 PEA and PIA |
45 PEA and PIA, rat stomach fundus strip data |
x |
| x |
| | #260 |
J. Med. Chem. |
23 |
294 |
1980 |
R. A. Glennon |
3 |
Lil |
| 4-, 5-, 6-(di)MeO- and MeS-DMT |
4-, 5-, 6-(di)MeO- and MeS-DMT, rat stomach fundus strip data, photoelectron
spectra |
| | x |
| | #261 |
J. Med. Chem. |
25 |
1381 |
1982 |
T. B. Kline |
3 |
Lil |
| tryptamine 1-C- and 2,3-dihydro analogues |
tryptamine 1-C- and 2,3-dihydro analogues, phenylalkylamines, rat stomach
fundus strip data |
| | x |
| | #262 |
J. Med. Chem. |
25 |
68 |
1982 |
R. A. Glennon |
3 |
Lil |
| 4-/5- MeO-/MeS-DMT |
4-/5- MeO-/MeS-DMT, rat drug discrimination data (5-MeO-DMT) |
| | x |
| | #263 |
Life Sci. |
30 |
465 |
1982 |
R. A. Glennon |
3 |
Lil |
| tryptamines hum. activity review |
tryptamines and beta-carbolines review, hum. activity data |
| | | x |
| #264 |
J. Psychoact. Drugs |
16 |
347 |
1984 |
D. J. McKenna |
3 |
Lil |
| 5-MeO-alpha-Me-tryptamine hum. activity |
5-MeO-alpha-Me-tryptamine, hum. activity |
| | | x |
| #266 |
J. Psychoact. Drugs |
11 |
247 |
1979 |
A. T. Shulgin |
3 |
Lil |
| DOB hum. activity |
DOB, hum. activity |
| | | x |
| #267 |
J. Psychoact. Drugs |
13 |
99 |
1981 |
A. T. Shulgin |
3 |
Lil |
| DOM hum. activity |
DOM, hum. activity |
| | | x |
| #268 |
J. Psychoact. Drugs |
9 |
171 |
1977 |
A. T. Shulgin |
3 |
Lil |
| (2,6-di-Me-) N-piperidyl analogs of 5-HT |
(2,6-di-Me-) N-piperidyl analogs of 5-HT, binding data for many 5-HT receptors,
poor 5-HT2 affinity |
x |
| x |
| | #269 |
Med. Chem. Res |
4 |
254 |
1994 |
M. Dukat |
3 |
Lil |
| agonist vs. antagonist label |
the effect 5-HT2A agonist, partial agonist, and antagonist radiolabels on binding affinity |
| | | | | #270 |
Biochem. Pharmacol. |
51 |
71 |
1995 |
A. J. Sleight |
3 |
Lil |
| 49 subst. phenylalkylamines |
49 phenylaklylamines, rabbit hyperthermia data, cat EEG data, rat open field
data |
x |
| x |
x |
| #271 |
J. Med. Chem. |
17 |
1100 |
1974 |
F. A. B. Aldous |
3 |
Lil |
| 13 4-subst PIA |
13 4-subst PIA, rat stomach fundus strip data, rat drug discrimination data
(DOM) |
x |
| x |
x |
| #272 |
J. Med. Chem. |
25 |
1163 |
1982 |
R. A. Glennon |
3 |
Lil |
| PEA-ergoline hybride |
PEA-ergoline hybride molecule as muscarinic antagonist, rat 5-HT1A (5-OH-DPAT) and 2A (ketanserin), cloned hum. 5-HT2A (ketanserin), 2B (rauwolscine), 2C (mesulergine), and cloned muscarinic receptor binding data, rat drug
discrimination data (LSD) |
x |
| x |
x |
| #273 |
J. Med. Chem. |
41 |
2134 |
1998 |
A. P. Monte |
3 |
Lil |
| 1-iso-N,N-dimethyl-tryptamines |
(6-MeO-/5-MeO-) 1-iso-N,N-dimethyl-tryptamines, rat 5-HT (serotonin) binding
data, rat drug discrimination data (DOM, 6-MeO-iso-DMT has 1/3 the activity of
5-MeO-DMT), rat stomach fundus strip data |
x |
| x |
x |
| #275 |
J. Med. Chem. |
27 |
41 |
1984 |
R. A. Glennon |
3 |
Lil |
| subst. alpha-Me-tryptamine enantiomers |
subst. alpha-Me-tryptamine enantiomers, rat 5-HT1 (serotonin) and 2 (ketanserin) binding data |
x |
| x |
| | #276 |
J. Med. Chem. |
31 |
1406 |
1988 |
D. E. Nichols |
3 |
Lil |
| amphetamine potentiation by 5-HT2A/2C agonists |
5-HT2A/2C agonists potentiate amphetamine stimulus cue, rat drug discrimination data
(amphetamine) |
| | | x |
| #277 |
Neuropharmacology |
36 |
1471 |
1997 |
D. Marona-Lewicka |
3 |
Lil |
| subst. N,N-dialkyltryptamines, CAR |
4-OH-, 5-OH-/AcO-, 4-/5-/6-/7-MeO-DMT, (5-MeO-) DET, rat conditioned avoidance
response test data, partition coeff. (psilocin is very lipophilic) |
| | x |
| | #278 |
Life Sci. |
7 |
267 |
1968 |
P. K. Gessner |
3 |
Lil |
| 5-HT analogues, uterus and fundus data |
24 5-HT analogues (N-subst, o-Bz), rat uterus and rat stomach fundus strip
data, many of them are antagonists |
| | | x |
| #279 |
Brit. J. Pharmacol. |
14 |
265 |
1959 |
R. B. Barlow |
3 |
Lil |
| 5-HT receptor ligands review |
review of 5-HT receptor ligands, 2-naphtyl-isopropylamine |
| | x |
| | #280 |
J. Med. Chem. |
30 |
1 |
1987 |
R. A. Glennon |
3 |
Lil |
| 5-HT receptor ligands review |
review of 5-HT receptor ligands, 1-naphtyl-isopropylamine |
| | x |
| | #281 |
Serotonin Receptor Subtypes: Basic and Clinical Aspects. Wiley-Liss, Inc. |
| 19 |
1991 |
R. A. Glennon |
3 |
Lil |
| MDL-aryloxyalkylimidazolines, 5-HT2A and 2C |
3 aryloxyalkylimidazolines and some agonists and antagonists, cloned rat 5-HT2A and 2C (I-LSD, 5-HT) receptor binding and efficiency data, 2 are weak agonists, 1 is
a weak antagonist |
| | x |
| | #282 |
Eur. J. Pharmacol. |
296 |
307 |
1996 |
B. W. Siegel |
3 |
Lil |
| 5-HT2 agonists and antagonists, 5-HT2A and 2C |
5-HT2 agonists and antagonists, cloned hum. 5-HT2A (ketanserin) and 2C (mesulergine) receptor binding and efficiency data |
| | x |
| | #283 |
J. Neurochem. |
67 |
2521 |
1996 |
R. A. Newton |
3 |
Lil |
| N-subst. (4-OH-, 5-oR-, 5-Me-, 6-MeO-) tryptamines |
21 N-subst. (4-OH-, 5-oR-, 5-Me-, 6-MeO-) tryptamines incl. N-cycl. analogues,
rat 5-HT2A (DOI, ketanserin) and 1A (8-OH-DPAT) binding data, 4-OH-tryptamines are selective for 5-HT2A vs. 1A |
| | x |
| | #284 |
Neuropharmacol. |
29 |
193 |
1990 |
D. J. McKenna |
3 |
Lil |
| 4-(2-butyl)-DMA isomers, 5-HT2A |
4-(2-butyl)-DMA isomers, rat 5-HT2A (DOI) binding data, rat drug discrimination data, no big difference between
isomers |
| | x |
x |
| #285 |
J. Med. Chem. |
38 |
3593 |
1995 |
R. Oberlender |
3 |
Lil |
| 4-subst. DMA |
27 4-subst DMA, rat 5-HT2 (ketanserin) binding data, rat thoracic aorta contraction data, longer
hydrophobic substituted DMA are antagonists |
| | x |
| | #286 |
J. Med. Chem. |
33 |
1032 |
1990 |
M. R. Seggel |
3 |
Lil |
| 27 subst. tryptamines, fundus data |
27 subst. tryptamines, rat stomach fundus strip data |
x |
| x |
| | #288 |
J. Med. Chem. |
22 |
427? |
1979 |
R. A. Glennon |
3 |
Lil |
| tetraline / indan DOM analogs |
tetraline / indan DOM analogs, rat CAR data, sheep umbilical artery data, rat
stomach fundus strip data, no / only weak DOM like activity |
x |
| x |
x |
| #323 |
J. Med. Chem. |
17 |
161 |
1974 |
D. E. Nichols |
3 |
Lil |
| 12 tryptamines incl. 7-subst., 2 PEA |
12 tryptamines incl. 7-subst., 2 PEA, rat drug discrimination, rat stomach
fundus strip data |
| | x |
x |
| #325 |
Psychopharmacology |
68 |
155 |
1980 |
R. A. Glennon |
3 |
Lil |
| phenyl-, benzoyl-piperazine amphetamine analogs |
5-MeO-2-(3-dimethylamino-1-oxopropyl)-aniline, phenylpiperazine and
bezoylpiperazine subst. amphetamine analogs, rat 5-HT1 (5-HT) and 2 (ketanserin) binding data, rat drug discrimination data (TFMPP, DOM), higher
5-HT1 affinities, some generalize to DOM |
x |
| x |
x |
| #327 |
J. Med. Chem. |
29 |
630 |
1986 |
R. A. Lyon |
3 |
Lil |
| phenyl-cyclobutylamine analogs of PIA |
phenyl-cyclobutylamine analogs of PIA, drug discrimination (LSD) data |
x |
| | x |
| #328 |
J. Med. Chem. |
27 |
1108 |
1984 |
D. E. Nichols |
3 |
Lil |
| 5-OH-DMT esters |
5-OH-DMT esters, rat stomach fundus strip data, partition coeff. data, all have
higher affinity than 5-MeO-DMT, 5-acetoxy-DMT has higher affinity than 5-OH-DMT |
x |
| x |
| | #329 |
J. Med. Chem. |
22 |
1414 |
1979 |
R. A. Glennon |
3 |
Lil |
| alpha-Me-5-HT, 2-Me-5-HT, 2-Me-5-MeO-T |
alpha-Me-5-HT, 2-Me-5-HT, 2-Me-5-MeO-T, rat 5-HT1A (8-OH-DPAT), 1B (5-HT), 2C (5-HT), bovine 5-HT1D (5-HT), human 5-HT1E (5-HT), rat 5-HT2 (ketanserin) receptor binding data |
x |
| x |
| | #330 |
J. Med. Chem. |
33 |
755 |
1990 |
A. M. Ismaiel |
3 |
Lil |
| 17 agonists and 12 antagonists binding data |
17 agonists incl. 14 tryptamines and LSD, and 12 antagonists, pig 5-HT1A (8-OH-DPAT), 1B (I-CYP), 2C (mesulergine), rat 5-HT2 (ketanserin) receptor binding data |
| | x |
| | #331 |
Arch. Pharmacol. |
332 |
1 |
1986 |
G. Engel |
3 |
Lil |
| 5-HT2C agonists, 1-isotryptamines |
5-F-6-Cl-indole synth, 5-HT2C agonists incl. subst. alpha-Me-1-isotryptamines and 5-F-alpha-MT, hum. 5-HT2A (DOB) and 2C (5-HT) receptor binding data, IP accumulation data, rat polydipsia model data,
rat penile erection data |
x |
| x |
| | #332 |
J. Med. Chem. |
40 |
2762 |
1997 |
M. Bös |
3 |
Lil |
| 5-HT2C agonists Ro 60-0175 and Ro 60-0332 |
5-HT2C agonists 5-Fl-6-Cl-alpha-Me-1-isotryptamine (Ro 60-0175) and Ro 60-0332,
pharmacological data |
x |
| x |
x |
| #333 |
J. Pharm. Exp. Ther. |
286 |
913 |
1998 |
J. R. Martin |
3 |
Lil |
| 5,N-subst. alpha-4 methylene bridged tryptamines |
5, N-subst. alpha/4 methylene bridged tryptamines, rat 5-HT1 (5-HT) and 5-HT2 (spiperone) binding data, some have good 5-HT2 binding affinities (antagonist labeled!) |
x |
| x |
x |
| #334 |
J. Med. Chem. |
31 |
1746 |
1988 |
M. E. Flaugh |
3 |
Lil |
| 5-acetyl-N,N-dipropyl alpha-4 methylene bridged T |
5-acetyl-N,N-dipropyl alpha-4 methylene bridged tryptamine LY293284, extensive
binding data, pharmacological data, specific for 5-HT1A |
x |
| x |
x |
| #334 |
J. Med. Chem. |
31 |
1746 |
1988 |
M. M. Foreman |
3 |
Lil |
| SK&F 103829 5-HT2 agonist |
SK&F 103829, a weak 5-HT2 partial agonist, pharmacological data |
| | x |
| | #335 |
Br. J. Pharmacol. |
111 |
264 |
1994 |
E. M. Taylor |
3 |
Lil |
| 26 5-HT2 ligands binding data |
review of 5-HT2C receptor pharmacology, 5-HT2C and 2A receptor binding data for 26 ligands |
| | x |
| | #337 |
TIPS |
9 |
89 |
1988 |
D. Hoyer |
3 |
Lil |
| tiflucarbine |
antidepressant tiflucarbine, rat drug discrimination (8-OH-DPAT, DOM,
5-MeO-DMT) data, 5-HT receptor binding review, effects probably not 5-HT2A or 1A receptor mediated |
| | | x |
| #338 |
Pharmacol. Biochem. Behav. |
37 |
769 |
1990 |
R. A. Glennon |
3 |
Lil |
| TFMPP and restricted (2-2' ethylen-bridged) TFMPP |
TFMPP and restricted (2-2' ethylen-bridged) TFMPP analog, 5-HT1 and 5-HT2 binding data |
x |
| x |
| | #339 |
J. Med. Chem. |
28 |
945 |
1985 |
J. R. Huff |
3 |
Lil |
| 5-HT receptor ligands review |
5-HT receptor ligands review |
| | | | | #340 |
Pharmacol. Biochem. Behav. |
40 |
1009 |
1991 |
R. A. Glennon |
3 |
Lil |
| LSD, DMT, DOI, and DOB binding data |
LSD, DMT, DOI, and DOB, hum. 5-HT1A (8-OH-DPAT), 1D (5-HT), 5-HT2A (ketanserin, DOB), alpha1-adrenergic, alpha2-adrenergic, beta-adrenergic,
muscarinic, and benzodiazepine receptor binding data |
| | x |
| | #341 |
Psychopharmacology |
97 |
118 |
1989 |
P. A. Pierce |
3 |
Lil |
| (6-MeO-) THBC |
(6-MeO-) THBC, rat drug discrimination (LSD) data, rat receptor (LSD) binding
data, (6-MeO-) THBC have weak LSD-type effects |
| | x |
x |
| #342 |
Life Sci. |
31 |
2433 |
1982 |
E. B. Nielsen |
3 |
Lil |
| DMT as at 5-HT2A agonist |
DMT binding and IP accumulation with hum. 5-HT2A and C receptor cell lines, rat drug discrimination tests with agonists and
antagonists |
| | x |
x |
| #189 |
Pharmacol. Biochem. Behav. |
61 |
323 |
1998 |
R. L. Smith |
2 |
Lil |
| DOB, DOM, MDA, and antagonists 5-HT2C activity |
DOB, DOM, MDA, and antagonists 5-HT2C activity, rat choroid plexus celles IP accumulation data |
| | x |
| | #383 |
Psychopharmacology |
105 |
340 |
1991 |
E. Sanders-Bush |
4 |
Lil |
| 17 DMA derivatives |
14 4-subst DMA derivatives, 3 N-subst DOB derivatives, cloned hum 5-HT2A, 2B, 2C, cloned rat 5-HT2B ([
3
H]5-HT, [
125
I]DOI) receptor binding data |
| | x |
| | #543 |
Arch. Pharmacol. |
359 |
1 |
1999 |
D. L. Nelson |
5 |
Lil |
| | | | | | | | | | | | | | | |
MAO |
subst amphetamines as MAO-A inhibitors |
31 subst. amphetamines incl. amphetamine, MTA, ETA, DOB, DOM, MDMA as
reversible MAO-A specific inhibitors, MTA and ETA have the highest activity and
MTA has a more than 1000 fold selectivity over MAO-B |
| | x |
| | #289 |
Biochem. Pharmacol. |
54 |
1361 |
1997 |
M. C. Scorza |
3 |
Lil |
| 1-Me-betaC and betaC binding sites |
1-Me-betaC and betaC binding sites in rat brain and liver |
| | x |
| | #290 |
Arch. Pharmacol. |
349 |
308 |
1994 |
T. May |
3 |
Lil |
| 22 MAOIs, MAO-A and MAO-B inhibition data |
22 substances (incl. 1-Me-betaCs, tryptamines, reversibel and irreversibel
MAOIs), MAO-A and MAO-B inhibition data, 1-Me-betaC binding to rat brain MAO,
1-Me-betaCs and 5-F-alphaMT are specific MAO-A inhibitors |
| | x |
| | #291 |
J. Neurochem. |
56 |
490 |
1991 |
T. May |
3 |
Lil |
| tryptamines and betaCs MAOI |
tryptamines and betaC in plant samples, self experiments, subst. tryptamines GC
data, THbetaCs MS data, MAO inhibition data for 10 subst. tryptamines incl.
psilocine, short review of subst. tryptamines and betaCs MAO inhibition |
| | x |
| | #292 |
J. Ethnopharmocol. |
12 |
179 |
1984 |
D. J. McKenna |
3 |
Lil |
| myristicin and nutmeg as MAO inhibitors |
myristicin and nutmeg as putative weak MAO inhibitors |
| | | x |
| #293 |
? |
? |
647 |
1963? |
E. B. Truitt |
3 |
Lil |
| tyramine pressor effect under moclobemide |
human tyramine pressor effect under moclobemide (reversible MAO-A-I), effect of
tyramine added to different meals |
| | | x |
| #294 |
J. Clin. Pharmacol. |
43 |
507 |
1992 |
C. Audebert |
3 |
Lil |
| tyramine in foods |
tyramine content of hundreds of foods, tyramine pressor effect review,
reversible vs. irreversible MAOI, mild cheeses, beer, wine, meat products in
normal amounts are ok, heavily fermented cheese and meat products only in small
amounts, MAOI after meal |
| | | | | #295 |
J. Neural Transm. (Suppl.) |
26 |
31 |
1988 |
M. Da Prada |
3 |
Lil |
| tyramine effect, reversible vs. irreversible MAOI |
human tyramine pressor effect under various reversible and irreversible MAOI,
tyramine-cheese has lower effects than pure tyramine |
| | | x |
| #296 |
J. Neural Transm. (Suppl.) |
26 |
21 |
1988 |
P. R. Bieck |
3 |
Lil |
| human tyramine effect under moclobemide |
human tyramine pressor effect under moclobemide (reversible MAO-A-I) or
tranylcypromine, effect of tyramine added to meal |
| | | | | #297 |
J. Neural Transm. (Suppl.) |
26 |
57 |
1988 |
A. Korn |
3 |
Lil |
| short comment on MAO-A-I |
short comment on MAO-A-I and the tyramine effect, no references |
| | | | | #298 |
J. Neural Transm. (Suppl.) |
26 |
123 |
1988 |
O. J. Rafaelsen |
3 |
Lil |
| human tyramine pressor effect under moclobemide |
human tyramine pressor effect under moclobemide (reversible MAO-A-I), tyramine
added to meal |
| | | | | #299 |
J. Neural Transm. (Suppl.) |
26 |
97 |
1988 |
R. Gieschke |
3 |
Lil |
| human tyramine pressor effect under moclobemide |
human tyramine pressor effect under moclobemide (reversible MAO-A-I), tyramine
added to meal, effect of MAOI ingestion before / with meal |
| | | | | #300 |
J. Neural Transm. (Suppl.) |
26 |
105 |
1988 |
T. Müller |
3 |
Lil |
| in vitro tests of MAOI - tyramine effects, review |
in vitro tests of MAOI - tyramine effects, review |
| | | | | #301 |
J. Neural Transm. (Suppl.) |
26 |
17 |
1988 |
B. A. Callingham |
3 |
Lil |
| review of reversible vs. irreversible MAO-A-I |
review of reversible vs. irreversible MAO-A specific inhibitors, tyramine
pressor effect, toxicity |
| | | | | #302 |
J. Neural Transm. (Suppl.) |
26 |
5 |
1988 |
M. Da Prada |
3 |
Lil |
| rat tyramine pressor effect under MAOI |
rat tyramine pressor effect under 4 reversible MAO-A-I or 1 irreversible MAOI |
| | | | | #303 |
J. Neural Transm. (Suppl.) |
26 |
11 |
1988 |
J. P. M. Finberg |
3 |
Lil |
| alpha-MT, alpha-Me-Trp, MAO inhibition |
(5-OH-) alpha-MT and -ET from indolecarbaldehydes, (5-OH)alpha-alkyl-Trp from
gramines and nitropropionates, MAO and 5-OH-Trp decarboxylase inhibition data |
x |
| x |
| » |
#30 |
J. Org. Chem. |
25 |
1548 |
1960 |
R. V. Heinzelmann |
1 |
Lil |
| | | | | | | | | | | | | | | |
tryptamines from indole (-aldehyde) |
5-OH-tryptamines, alpha-MT, 5-BzO-indole |
5-OH-tryptamines and alpha-MT from indole via 3-formyl-indole,
nitroalkenylindole, 5-BzO-indole from p-BzO-aniline via phenylhydrazone and
5-BzO-indole-2-carboxylate, yield 60% |
x |
| | | | #306 |
J. Chem. Soc. |
- |
3887 |
1958 |
A. S. F. Ash |
3 |
Lil |
| indole-3-Zn reactions |
many (1- or 2-substituted) indoles, indole-3-acetic acids from indoles with
n-BuLi and ZnCl2 |
| x |
| | | #307 |
J. Med. Chem. |
39 |
5119 |
1996 |
R. D. Dillard |
3 |
Lil |
| indole 3-alkylation by alcohols |
indole 3-alkylations by alcohols in refluxing p-cymene (183°C) with NaOH,
nickel catalyst, and water removal |
| x |
| | | #308 |
J. Am. Chem. Soc. |
79 |
5248 |
1957 |
E. F. Pratt |
3 |
Lil |
| (5-OH-)(alpha-alkyl-)tryptamines |
(5-OH-)(alpha-alkyl-)tryptamines from indoles via 3-formyl-indoles with
Vilsmeier formylation, 3-nitroalkenyl-indoles with nitroalkan and ammonium
acetate at reflux, first paper for this route |
| | | | | #317 |
J. Chem. Soc. |
- |
3493 |
1958 |
E. H. P. Young |
3 |
Lil |
| 5-EtO-T |
5-EtO-T from 2-NO2-5-OH-toluene via 2-NO2-5-EtO-toluene, 2-NO2-phenylpyruvate, 2-hydrazo-phenylpyruvate, 2-COOEt-indole (very poor yield),
2-COOH-indole, indole, indolyl-MgBr, indolylacetonitril with Cl-acetonitril,
method ref. #110 + Ann. 513, 1 1934 |
x |
| | | | #318 |
Ann. |
516 |
76 |
1935 |
T. Hoshino |
3 |
Lil |
| 5-F-indole, 5-F-DMT, 5-F-DET |
5-F-DMT and 5-F-DET from 3-F-toluene, 3-F-benzaldehyde, 3-F-6-NO2-benzaldehyde, 3-F-6-NO2-nitrostyrene, 5-F-indole, yield 29% over all, Speeter / Anthony route |
x |
| | | | #319 |
J. Chem. Soc. |
- |
5418 |
1961 |
Z. Pelchowicz |
3 |
Lil |
| 4-, 5-, 6-, and 7-isotryptamines |
4-, 5-, 6-, and 7-isotryptamines from formylindoles |
x |
| | | | #305 |
Helv. Chim. Acta |
51 |
1616 |
1968 |
F. Troxler |
3 |
Lil |
| alpha-MT, alpha-Me-Trp |
(5-OH)alpha-MT and -ET from indolecarbaldehydes, (5-OH)alpha-alkyl-Trp from
gramines and nitropropionates, MAO and 5-OH-Trp decarboxylase inhibition data |
x |
| x |
| | #30 |
J. Org. Chem. |
25 |
1548 |
1960 |
R. V. Heinzelmann |
1 |
Lil |
| subst. tryptamines |
many, many tryptamines through Abramovich, indolylacetone reductive amination,
indolylmagnesiumbromide, indolylcarbaldehyde and gramine with nitroalkanes,
tryptamine acylation / LiAlH4 reduction... |
x |
| | | » |
#43 |
J. Chem. Soc. |
- |
7165 |
1965 |
B. Heath-Brown |
1 |
Lil |
|
indole-3-acylation and reduction with NaBH4 / TFA |
1-phenylsulfonyl-indole 3-acylation with RCOCl / AlCl3, yields > 81%, reduction to 1-phenylsulfonyl-3-alkyl-indoles with NaBH4 / TFA yields > 96% |
| | | | | #546 |
J. Org. Chem. |
50 |
5451 |
1985 |
D. M. Ketcha |
5 |
Lil |
| | | | | | | | | | | | | | | |
designer drugs |
designer drugs review |
designer drugs: amphetamine analogs review, mescaline SPECT study |
| | | x |
| #345 |
Pharm. i. u. Zeit |
19 |
99 |
1990 |
K. A. Kovar |
4 |
Lil |
| designer drugs review |
designer drugs: amphetamine analogs analytics, DC, Rf of 16 substances in 4
solvent systems, colour reactions, UV, IR, and
1
H- and
13
C-NMR spectra, DC-IR |
| | | x |
| #346 |
Pharm. i. u. Zeit |
19 |
211 |
1990 |
K. A. Kovar |
4 |
Lil |
| structure and activity of hallucinogens review |
structure and activity of hallucinogens review |
| | | | | #347 |
Chem. i. u. Zeit |
13 |
147 |
1979 |
W. Hänsel |
4 |
Lil |
| designer drug review |
designer drug review: amphetamine, PCP, fentanyl, and prodine analogs, list of
suspected chemicals |
| | | | | #349 |
Dtsch. Apoth. Zeitg. |
127 |
1569 |
1987 |
K. A. Kovar |
4 |
Lil |
| futute synthetic drugs of abuse |
future synthetic drugs of abuse, many compound classes, many references |
| | | | | #350 |
available from WWW |
? |
? |
? |
D. A. Cooper |
4 |
Lil |
| short review |
short review on hallucinogens, entactogens and phencyclidins |
| | | | | #465 |
??? |
? |
? |
? |
? |
? |
Lil |
| | | | | | | | | | | | | | | |
reviews |
hallucinations review |
hallucinations classification and reporting methods review, no refs. |
| | | | | #344 |
Scient. Am. ? |
? |
132 |
1974? |
R. K. Siegel |
4 |
Lil |
| good old review of psychotomimetics chemistry |
good old review of psychotomimetic chemistry |
x |
x |
| | | #348 |
Medicinal Chemistry, Ed. G. deStevens, Psychopharmacological Agents Vol. 1, Ed.
M. Gordon, Academic Press, NY |
4-1 |
555 |
1964 |
D. F. Downing |
4 |
Lil |
|
indole review |
indole chemistry review |
| x |
| | | #574 |
Indoles, Best Synthetic Methods Series, Academic Press, San Diego, CA |
16 |
- |
1996 |
R. J. Sundberg |
5 |
Lil |
| | | | | | | | | | | | | | | |
lysergamides |
1-Me-lysergic acid butanolamide potentiates DMT effects |
1-Me-lysergic acid butanolamide (UML-491) potentiates DMT effects in human |
| | | x |
| #351 |
Experientia |
58 |
137 |
1962 |
A. Sai-Halász |
4 |
Lil |
| ergot alkaloids review |
extensive review on ergot alkaloids |
| | | | | #352 |
Die Mutterkornalkaloide, Sammlung Chem. Techn. Beitr., Ferdinand Enke Verlag,
Stuttgart |
60 |
- |
1964 |
A. Hofmann |
4 |
Lil |
| ergoline derivatives review |
review on ergolin derivatives as pharmaceuticals |
| | | | | #353 |
Pharmaz. Zeitg. |
137 |
9 |
1992 |
E. Eich |
4 |
Lil |
| lysergamides from mixed anhydride activation |
lysergamides from mixed anhydride activation, LiOH / SO3 method |
x |
| | | | #354 |
J. Org. Chem. |
24 |
368 |
1959 |
W. L. Garbrecht |
4 |
Lil |
| N-alkyl-nor-LSD derivatives |
N(6)-alkyl-nor-LSD derivativesrat drug discrimination data |
x |
| | x |
| #355 |
J. Med. Chem. |
28 |
1252 |
1985 |
A. J. Hoffman |
4 |
Lil |
| mono-(2-alkyl)-lysergamides |
mono-(2-alkyl)-lysergamides via POCl3 method, rat 5-HT1A (8-OH-DPAT) and 2A (ketanserin) binding data, rat drug discrimination (LSD)
data, crystal structures, some have LSD-like activity, all have higher 5-HT1A affinities |
x |
| x |
x |
| #356 |
J. Med. Chem. |
38 |
958 |
1995 |
A. P. Monte |
4 |
Lil |
| slow dissociation of LSD and BOL from 5-HT2A receptor |
slow dissociation of LSD and BOL from 5-HT2A receptor, cloned rat membrane 5-HT2A binding data, t1/2 = 20 min, PI accumulation data |
| | x |
| | #357 |
Mol. Pharmacol. |
42 |
826 |
1992 |
K. D. Burris |
4 |
Lil |
| alkyl--isopropyl-lysergamides |
alkyl-isopropyl-lysergamides, rat 5-HT1A (8-OH-DPAT) and 2A (ketanserin) binding data, rat drug discrimination (LSD)
data, crystal structures,all have LSD-like activity, all have higher 5-HT1A affinities |
x |
| x |
x |
| #358 |
J. Med. Chem. |
38 |
958 |
1995 |
A. P. Monte |
4 |
Lil |
| LSD as 5-HT2C receptor agonist |
LSD, but not BOL and lisuride, as 5-HT2C receptor agonist, rat IP accumulation data |
| | x |
| | #359 |
J. Pharm. Exp. Ther. |
258 |
891 |
1991 |
K. D. Burris |
4 |
Lil |
| LSD-like effects of methylergonovine in human |
LSD-like effects of methylergonovine and related compounds in human |
| | | x |
| #360 |
J. Psyched. Drugs |
12 |
165 |
1980 |
J. Ott |
4 |
Lil |
| LSD, psilocybin, and TMA-2 crystal structures |
LSD, psilocybin, and TMA-2 X-ray crystal structures |
| | | | | #361 |
Mol. Pharmacol. |
9 |
23 |
1973 |
R. W. Baker |
4 |
Lil |
| lysergic acid total synthesis |
lysergic acid 15 step total synthesis |
| | | | | #362 |
J. Am. Chem. Soc. |
78 |
3087 |
1978 |
E. C. Kornefeld |
4 |
Lil |
| lysergic acid total synthesis |
lysergic acid total synthesis |
| x |
| | | #365 |
J. Am. Chem. Soc. |
76 |
5256 |
1954 |
E. C. Kornefeld |
4 |
Lil |
| effects of LSD analogs in human |
physical and psychic effects of LSD analogs in human |
| | | | | #368 |
Psychopharmacologia |
1 |
20 |
1959 |
H. Isbell |
4 |
Lil |
| LSD and psilocybin in human |
physical and psychic effects of LSD and psilocybin in human |
| | | | | #369 |
Psychopharmacologia |
1 |
29 |
1959 |
H. Isbell |
4 |
Lil |
| LSD antagonism on 5-HT2 IP accumulation |
LSD antagonism on serotonin induced rat cortex 5-HT2 IP accumulation |
| | | | | #370 |
J. Pharm. Exp. Ther. |
247 |
918 |
1988 |
P. A. Pierce |
4 |
Lil |
| dopamine D1 binding data of LSD analogs |
LSD N6- and amide-analogs, rat dopamine D1 binding data (SCH23390), AC activity test data |
| | | | | #371 |
Psychopharmacology |
118 |
401 |
1995 |
V. J. Watts |
4 |
Lil |
| methyl-propinyl-lysergamide |
methyl-propinyl-lysergamide (LEK 8842) and analogs, 5-HT2 and alpha-adrenoceptors isolated rat aorta contraction data |
| | | | | #372 |
Pharmacology |
45 |
195 |
1992 |
I. Krisch |
4 |
Lil |
| 13- and 14-tBu lysergamides |
13- and 14-tBu lysergamides and -reverse amides, rat alpha1, alpha2, D1, D2,
5-HT1A and 5-HT2 binding data, 14-t-butylation enhances affinities by 10 - 200 times |
x |
| x |
| | #373 |
Bioorg. Med. Chem. Lett. |
8 |
1117 |
1998 |
S. Mantegani |
4 |
Lil |
| | | | | | | | | | | | | | 4 |
Lil |
LSD metabolism |
[
14
C]LSD metabolism in rat liver, 12-OR-LSD data |
[
14
C]LSD metabolism in perfused rat liver, synthesis, MS data, Rf values, and
colour reactions (incl. 5-, 6-, 7-OH-indole) of metabolites incl. 12-OH-LSD |
x |
| | | | #363 |
Biochem. Pharmacol. |
28 |
3081 |
1979 |
Z. H. Siddik |
4 |
Lil |
| [
14
C]LSD metabolism in rat, guinea pig, and monkey |
[
14
C]LSD metabolism in rat, guinea pig, and rhesus monkey, strong species
differences |
| | | | | #364 |
Biochem. Pharmacol. |
28 |
3093 |
1979 |
Z. H. Siddik |
4 |
Lil |
| [
14
C]LSD distribution in mouse |
[
14
C]LSD distribution and fate in mouse |
| | | | | #366 |
Experientia |
11 |
396 |
1955 |
A. Stoll |
4 |
Lil |
| [
14
C]LSD distribution in mouse |
[
14
C]LSD distribution in mouse after intracerebral and intravenous injection |
| | | | | #367 |
Experientia |
13 |
199 |
1957 |
T. J. Haley |
4 |
Lil |
| 12-OH-lysergamide from lysergamide |
12-OH-lysergic acid butanolamide from lysergamide via Zn / HCl reduction to
2,3-dihydro-lysergamide and oxidation with potassium nitroso disulphonate NO(SO3K)2 |
| x |
| | | #374 |
Helv. Chem. Acta |
47 |
756 |
1964 |
P. A. Stadler |
4 |
Lil |
| | | | | | | | | | | | | | | |
simplified LSD analogs |
depyrrolo-LSD |
depyrrolo-LSD synthesis, patent Fr 1,555,553, paper see #0375 |
x |
| | | | #375 |
CA |
72 |
100543j |
1970 |
M. Julia |
4 |
Lil |
| depyrrolo-LSD |
depyrrolo-LSD synthesis |
x |
| | | | #376 |
Bull. Soc. Chim. |
? |
4463 |
1968 |
M. Julia |
4 |
Lil |
| depyrrolo-de-C4-LSD |
depyrrolo-de-C4-LSD synthesis, highly active in reversing ileal contraction through ergonovine |
x |
| | x |
| #377 |
J. Org. Chem. |
39 |
1669 |
1974 |
J. C. Craig |
4 |
Lil |
| depyrrolo-methyl lysergate via photocyclization |
depyrrolo-methyl lysergate via photocyclization |
| x |
| | | #378 |
J. Chem. Soc. Perk I |
- |
2911 |
1984 |
I. Ninomiya |
4 |
Lil |
| depyrrolo-LSD |
depyrrolo-LSD 5-step synthesis, depyrrolo-ethyl lysergate is a potent oxytocics |
x |
| | x |
| #379 |
Chem. Pharm. Bull. |
15 |
1641 |
1967 |
Z. Horii |
4 |
Lil |
| depyrrolo-ethyl lysergate |
depyrrolo-ethyl lysergate 4-step synthesis |
| x |
| | | #380 |
Chem. Pharm. Bull. |
15 |
1641 |
1967 |
Z. Horii |
4 |
Lil |
| chemistry of (depyrrolo-) lysergic acid derivatives |
isomerizations of (depyrrolo-) lysergic acid derivatives, depyrrolo synthesis
ref: T. Kiguchi Het. 19, 873 1982, Het. 18, 217 1982, Het. 22, 43 1984 |
| | | | | #381 |
Het. |
22 |
1719 |
1984 |
T. Kiguchi |
4 |
Lil |
| | | | | | | | | | | | | | | |
5-NonO-tryptamines |
NonO-tryptamine |
NonO-tryptamine, serotonin, and sumatriptan, 5-HT1A, 1B, 1Dalpha, 1Dbeta, 2A, 2C, and 3 receptor binding data, AC activity data |
x |
| x |
| | #384 |
J. Med. Chem. |
37 |
2828 |
1994 |
R. A. Glennon |
4 |
Lil |
| alkylO-tryptamine |
37 subst. 5-alkyl-O- and 5-alkanoyl-O-tryptamines and cyclic analogs, human 5-HT1A, 1Dalpha, and 1Dbeta receptor binding data, NonO-DMT from tryptamine with NaCNBH4, formaline, and acetic acid, yield 25% |
x |
| x |
| | #385 |
J. Med. Chem. |
39 |
314 |
1996 |
R. A. Glennon |
4 |
Lil |
| p-alkylO-anilines |
p-alkylO-anilines from p-OH-formanilide via p-alkoxyformanilide with alkyl
bromide, and alkaline hydrolysis |
| x |
| | | #386 |
J. Chem. Soc. |
- |
1573 |
1955 |
Ph. Buu-Hoï |
4 |
Lil |
| p-alkylO-anilines |
p-alkylO-anilines from p-OH-acetanilide via p-alkoxyacetanilide with alkyl
bromide, and alkaline hydrolysis |
| x |
| | | #387 |
J. Med. Chem. |
27 |
347 |
1984 |
C. D. Selassie |
4 |
Lil |
| p-pentyl-O-phenylhydrazine |
p-pentyl-O-phenylhydrazine from p-pentyl-O-aniline with 1. NaNO2 / HCl 2. SnCl2 / HCl |
| x |
| | | #388 |
J. Med. Chem. |
15 |
307 |
1972 |
E. M. Kosower |
4 |
Lil |
| p-alkylO-anilines |
p-alkylO-anilines from p-OH-trifluoroacetanilide via
p-alkoxy-trifluoroacetanilide with alkyl bromide, and gentle alkaline hydrolysis |
| x |
| | | #389 |
Coll. Czech. Chem. Commun. |
38 |
595 |
1972 |
M. Machková |
4 |
Lil |
| | | | | | | | | | | | | | | |
MDMA |
2- / 5- / 6-Me-MDA |
2- / 5- / 6-Me-MDA, rat drug discrimination data ((+)-amphetamine, (+)-MBDB,
MMAI, LSD, DOI), rat synaptosomes monoamine uptake inhibition data (5-HT, DA,
NE), they are potent and specific 5-HT uptake inhibitors and generalize to MBDB
and MMAI |
x |
| x |
x |
| #409 |
J. Med. Chem. |
41 |
1001 |
1998 |
M. A. Parker |
4 |
Lil |
| MDMA and LSD synergism |
strong synergism between MDMA and LSD in rat drug discrimination (MDMA) test |
| | | x |
| #410 |
Eur. J. Pharmacol. |
341 |
131 |
1998 |
M. D. Schechter |
4 |
Lil |
| beta-oxo-MDA / -MDMA, N-subst. cathinones |
beta-oxo-MDA and -MDMA, rat drug discrimination data ((+)-amphetamine, DOM,
MDMA), N-subst cathinone = beta-oxo-amphetamine rat drug discrimination data
((+)-amphetamine) |
x |
| | x |
| #411 |
Pharmacol. Biochem. Behav. |
58 |
1109 |
1997 |
T. A. Dal Cason |
4 |
Lil |
| subst. amphetamines review |
hallucinogenic and serotonin releasing subst. amphetamines medicinal chemistry
and structure-activity relationships review |
| | | | | #412 |
Amphetamine and its Analogs: Pharmacology, Toxicology, and Abuse, Ed. A. K.
Cho, Academic Press, San Diego, CA |
1 |
3 |
1994 |
D. E. Nichols |
4 |
Lil |
| MDA and DOM indane and tetraline analogs |
MDA 1-beta, 6-beta, and DOM 6-beta methylene and ethylene bridged indane and
tetraline analogs, rat drug discrimination data (LSD, MDMA), rat monoamine
(-metabolites) and paroxetine Bmax long term effects, 1-beta-methylene-MDA generalizes + non-neurotoxic |
x |
| x |
x |
| #413 |
J. Med. Chem. |
33 |
703 |
1990 |
D. E. Nichols |
4 |
Lil |
| MTA |
MTA, rat drug discrimination data (MDMA, (S)-MBDB, MMAI), rat monoamine
(-metabolites) long term effects, rat synaptosomes 5-HT-, dopamine-, and
NE-uptake inhibition data, rat cortex slice 5-HT-releasing data, MTA
generalizes and is non-neurotoxic |
x |
| x |
x |
| #414 |
Eur. J. Pharmacol. |
229 |
31 |
1992 |
X. Huang |
4 |
Lil |
| hormone effects of MBDB, MMAI, and MTA |
MBDB, MMAI, MTA effects on secretion of the hormones ACTH, corticosteron,
prolactin, oxytocin, and renin |
| | | x |
| #415 |
J. Pharm. Exp. Ther. |
279 |
1261 |
1996 |
Q. Li |
4 |
Lil |
| MDA-methylendioxy analogs |
MDA TH-benzofuran, indan, and tetralin methylendioxy-analogs, rat drug
discrimination data (MMAI, (S)-MBDB, (S)-amphetamine), rat synaptosomes 5-HT-,
dopamine-, and NE-uptake inhibition data |
x |
| x |
x |
| #416 |
J. Med. Chem. |
36 |
3700 |
1993 |
A. P. Monte |
4 |
Lil |
| MDMA neurotoxicity and free radicals |
MDMA neurotoxicity through free radicals, rat monoamine (-metabolites) long
term effects, microdialysis salicylic acid scavenging |
| | | x |
| #417 |
Br. J. Pharmacol. |
121 |
889 |
1997 |
M. I. Colado |
4 |
Lil |
| MDMA neurotoxicity, ascorbate and cysteine |
MDMA neurotoxicity, ascorbate and cysteine before and after MDMA, rat 5-HT long
term effects, ascorbate and cysteine prevent 5-HT long term effects |
| | | x |
| #418 |
J. Neural Transm. |
103 |
1397 |
1996 |
G. A. Gudelsky |
4 |
Lil |
| 3-MeO-4-Me-amphetamine, MMAI, 5,6-methylendioxy-2-aminoindane |
3-MeO-4-Me-amphetamine, MMAI, 5,6-methylendioxy-2-aminoindane, rat drug
discrimination data (MDMA, (S)-MBDB, LSD, (S)-amphetamine), rat monoamine
(-metabolites) and Bmax long term effects, rat synaptosomes 5-HT uptake inhibition data |
x |
| x |
x |
| #419 |
J. Med. Chem. |
34 |
1662 |
1991 |
M. P. Johnson |
4 |
Lil |
| MMAI mechanism |
MMAI mechanism of action, rat drug discrimination data (MMAI, MMAI +
antagonists or uptake inhibitors, MMAI after p-Cl-Phe), rat adrenoceptor
binding data, rat behavioural effects after MMAI and MMAI after p-Cl-Phe |
x |
| | x |
| #420 |
Eur. J. Pharmacol. |
258 |
1 |
1994 |
D. Marona-Lewicka |
4 |
Lil |
| 5-IAI |
5-I-2-aminoindan, rat drug discrimination data (MDMA, (S)-MBDB), rat monoamine
(-metabolites) long term effects, rat synaptomes 5-HT uptake inhibition data |
| | x |
x |
| #421 |
Pharmacol. Biochem. Behav. |
38 |
135 |
1991 |
D. E. Nichols |
4 |
Lil |
| alpha-ethyl PCA analog = CAB |
CAB = alpha-ethyl PCA analog, rat drug discrimination data (MDMA, (S)-MBDB),
rat monoamine (-metabolites) acute and long term effects, rat long term
paroxetine binding data, rat synaptosomes 5-HT- and dopamine-uptake inhibition
data |
| | x |
x |
| #423 |
Eur. J. Pharmacol. |
191 |
1 |
1990 |
M. P. Johnson |
4 |
Lil |
| | | | | | | | | | | | | | | |
| alpha-ethyl-tryptamine, AMT, alpha-ethyl DOM analog |
alpha-ethyl-tryptamine, AMT, alpha-ethyl DOM analog, rat drug discrimination
data (MDMA, amphetamine) |
| | | x |
| #425 |
Pharmacol. Biochem. Behav. |
46 |
459 |
1993 |
R. E. Glennon |
4 |
Lil |
| hyponatraemia after MDMA |
hyponatraemia after MDMA and VP oversecretion |
| | | x |
| #426 |
Lancet |
347 |
1052 |
1996 |
R. Holden |
4 |
Lil |
| | | | | | | | | | | | | | | |
| MDMA THIQ, indane, and tetraline analogs |
(N-Me-) 5,6-/4,5-methylendioxy-2-aminoindan, -THIQ,
6,7-methylendioxy-2-aminotetralin, mouse locomotor activity and rearing, hum.
5-HT2A (ketanserin, DOB) binding data, rat drug discrimination data (MDMA) |
x |
| x |
x |
| #428 |
Med. Chem. Res. |
- |
412 |
1996 |
L. Malmusi |
4 |
Lil |
| (+)-MDA vs. (-)-MDA |
rat drug discrimination data ((+)-MDA vs. (-)-MDA vs. saline) |
| | | x |
| #430 |
J. Pharm. Exp. Ther. |
276 |
594 |
1996 |
R. Young |
4 |
Lil |
| MDMA long term neurotoxicity |
MDMA neurotoxicity over 52 weeks, rat monoamine (-metabolites) long term effects |
| | x |
x |
| #431 |
J. Pharm. Exp. Ther. |
276 |
846 |
1996 |
K. E. Sabol |
4 |
Lil |
| MDMA long term neurotoxicity |
MDMA neurotoxicity over 52 weeks, rat 5-HT- and dopamine uptake binding site
autoradiography data |
| | x |
x |
| #432 |
J. Pharm. Exp. Ther. |
276 |
855 |
1996 |
R. Lew |
4 |
Lil |
| MDMA toxicity review |
MDMA toxicity review |
| | | | | #433 |
Psychopharmacol. |
119 |
247 |
1995 |
A. R. Green |
4 |
Lil |
| MDMA metabolites acute effects |
MDMA metabolites, different metabolizing rats acute 5-HT depletion effect |
| | x |
x |
| #434 |
Biochem. Pharmacol. |
51 |
789 |
1996 |
T. Chu |
4 |
Lil |
| alpha-ethyl-tryptamine |
alpha-ethyl-tryptamine, rat behavioural changes, fluoxetine pretreatment |
| | | x |
| #435 |
Psychopharmacol. |
113 |
284 |
1993 |
K. M. Krebs |
4 |
Lil |
| PCA neurotoxicity |
PCA neurotoxicity after MAOI or 5-HT2A antagonist pretreatment, PCA is different from MDMA neurotoxicity |
| | x |
x |
| #436 |
Biochem. Pharmacol. |
52 |
1271 |
1996 |
J. E. Sprague |
4 |
Lil |
| 5-HT releasers review |
5-HT releasers review, neurotoxicity from dopamine / 5-HT release, MMAI binding
data, rat synaptosomes monoamines uptake inhibition data, MMAI rat brain slice
5-HT release data |
| | x |
x |
| #437 |
Drug Des. Disc. |
9 |
299 |
1993 |
D. E. Nichols |
4 |
Lil |
| MDMA neurotoxicity and MAO-B-I |
MDMA neurotoxicity after the MAO-B-I deprenyl, rat brain paroxetine binding BMAX and 5-HT (-metabolite) long term effects, rat brain acute radical formation
markers |
| | x |
x |
| #438 |
J. Pharm. Exp. Ther. |
273 |
667 |
1995 |
J. E. Sprague |
4 |
Lil |
| glutathionyl-alpha-methyldopamine |
2,5-bis-glutathionyl-alpha-methyldopamine (MDMA and MDA metabolite)
neurotoxicity, rat behaviour data, rat monoamine (-metabolites) long term
effects |
| | x |
x |
| #445 |
Eur. J. Pharmacol. |
323 |
173 |
1997 |
R. T. Miller |
4 |
Lil |
| | | | | | | | | | | | | | | |
fenfluramine |
PMMA |
PMMA and amphetamine, DOM, PMA, MDMA, 3,4-DMA, fenfluramine, alpha-ethyl PMMA
analog, rat drug discrimination data (PMMA), generalization only to MDMA and
(S)-MDMA |
| | | x |
| #422 |
Pharmacol. Biochem. Behav. |
57 |
151 |
1997 |
R. E. Glennon |
4 |
Lil |
| fenfluramine |
fenfluramine effects in human, reporting of ant-aggressive and sedating effects
and peacefule, tolerant, friendly, affable, compliant, benevolent, and calm up
feelings |
| | | x |
| #424 |
J. Psychopharmacol. |
9 |
1 |
1995 |
A. J. Bond |
4 |
Lil |
| fenfluramine |
neurotoxic (+)-fenfluramine pretreatment on rat drug discrimination data (MDMA) |
| | | x |
| #427 |
Pharmacol. Biochem. Behav. |
53 |
455 |
1996 |
L. E. Baker |
4 |
Lil |
| fenfluramine |
serotonergic drugs, Fawn Hooded strain rat drug discrimination data
(fenfluramine) |
| | x |
| | #448 |
Life Sci. |
60 |
PL 83 |
1996 |
M. D. Schechter |
4 |
Lil |
| | | | | | | | | | | | | | | |
piperazines |
subst. benzylpiperazines |
MDMA neurotoxicity after coadministration with H-, p-Cl-, p-MeO-, and p-NO2-3,4-methylendioxy-benzylpiperazine, rat 5-HT (-metabolite) long term effects,
rat 5-HT tarnsporter binding data (6-nitroquipazine) |
| | x |
x |
| #439 |
Brain Res. |
590 |
341 |
1992 |
K. Hashimoto |
4 |
Lil |
| subst. benzylpiperazines |
MDMA acute effects after coadministration with H-, p-Cl-, p-MeO-, and p-NO2-3,4-methylendioxy-benzylpiperazine, rat 5-HT (-metabolite) acute effects, rat
synaptosomes 5-HT uptake inhibition data |
| | x |
x |
| #444 |
Neurosci. Lett. |
152 |
17 |
1993 |
K. Hashimoto |
4 |
Lil |
| subst. benzylpiperazines |
MDMA tissue distribution time course after pretreatment with monoamine uptake
inhibitors and methylendioxybenzylic compounds incl. piperonylpiperazine |
| | | x |
| #443 |
Eur. J. Pharmacol. |
228 |
247 |
1992 |
K. Hashimoto |
4 |
Lil |
| piperonylpiperazine |
MDMA neurotoxicity after coadministration with piperonylpiperazine,
N,alpha-piperonylamine, paroxetine and 6-nitroquipazine, rat 5-HT (-metabolite)
long term effects, rat 6-nitroquipazine BMAX binding data long term effect |
| | x |
x |
| #449 |
Eur. J. Pharmacol. |
228 |
171 |
1992 |
K. Hashimoto |
4 |
Lil |
| | | | | | | | | | | | | | | |
MDMA and 5-HT3 |
MDMA and 5-HT3 antagonists |
MDMA blocks MDL72222 (5-HT3 antagonist) conditioned place preference |
| | | x |
| #446 |
Pharmacol. Biochem. Behav. |
39 |
509 |
1991 |
E. J. Bilsky |
4 |
Lil |
| MDMA and 5-HT antagonists |
5-HT3 antagonists antagonize MDMA stimulus, 2-Me-5-HT and various 5-HT antagonists,
rat drug discrimination data (MDMA), |
| | x |
| | #447 |
Pharmacol. Biochem. Behav. |
43 |
1099 |
1992 |
R. A. Glennon |
4 |
Lil |
| | | | | | | | | | | | | | | |
hydroxylamines |
aryl-ethyl-hydroxylamines |
subst. amphetamine and AMT hydroxylamine analogs, pharmacological data, synth.
from ketone, via oxime with hydroxylamine and reduction with H2 / Pdo / EtOH / HCl |
x |
| x |
x |
| #440 |
J. Med. Chem. |
8 |
100 |
1965 |
F. Benington |
4 |
Lil |
| indolyl-ethyl-hydroxylamines |
ring,alpha-subst. tryptamine hydroxylamine analogs from nitroalkanes (from
gramines and nitroalkanes) with Zn / NH4Cl, yields 57% - 75%, or from indolylacetone with hydroxylamine and reduction
with H2 / Pdo / EtOH / HCl, yield 24% |
x |
| | | | #441 |
J. Chem. Soc. |
- |
7179 |
1965 |
A. Cohen |
4 |
Lil |
| indolyl-ethyl-hydroxylamines |
patent Brit. 990,092, for paper see #0441 |
x |
| | | | #443 |
CA |
63 |
2959 |
1965 |
A. Cohen |
4 |
Lil |
| AMT (hydroxylamine) analogs |
AMT (hydroxylamine) analogs, metabolism of hydroxylamines to amines, guinea pig
liver MAO inhibition (5-HT) data, mouse tremor time course, mouse
pharmacological data, rat tissue distribution and metabolism data |
| | x |
x |
| #442 |
Biochem. Pharmacol. |
15 |
481 |
1966 |
A. W. Lessin |
4 |
Lil |
receptor binding site |
| 5-HT2A receptor model, fitting of ketanserin-like antagonists and DOM-like agonists,
correlation between predicted and experimental affinities |
| | x |
| | #451 |
Arch. Pharm. |
328 |
577 |
1995 |
H.-D. Höltje |
4 |
Lil |
| | 5-HT2A receptor aromatic residue mutations and agonist binding, 5-HT, bufotenine,
DOM, and alpha-Me-5-HT binding (ketanserin) and IP accumulation data |
| | x |
| | #452 |
J. Pharm. Exp. Ther. |
52 |
259 |
1997 |
B. L. Roth |
4 |
Lil |
| | 5-HT2A receptor TM3 Ser mutants and ligand amino substitutions, 5-HT, bufotenine, and
LSD binding data (ketanserin) |
| | x |
| | #453 |
J. Biol. Chem. |
271 |
14672 |
1996 |
N. Almaula |
4 |
Lil |
| | 5-HT receptor models review |
| | | | | #454 |
J. Pharm. Pharmacol. |
47 |
791 |
1995 |
Z. Chilmonczyk |
4 |
Lil |
| | 5-HT1A receptor model, fitting of antagonists and agonists |
| | | | | #460 |
Drug Des. Discov. |
11 |
231 |
1994 |
W. Kuipers |
4 |
Lil |
| | 5-HT1Dbeta and 5-HT1E receptor TM6 residue mutations and chimeras, 11 ligands binding data (5-HT) |
| | x |
| | #461 |
J. Neurochem. |
67 |
2096 |
1996 |
E. M. Parker |
4 |
Lil |
| | differences between 5-HT2A and 5-HT2C receptors, agonists and antagonists (+GTP) 5-HT2A and 5-HT2C receptor binding data (DOI, 5-HT, mesulergine, ketanserin), binding states |
| | x |
| | #463 |
Mol. Pharmacol. |
42 |
328 |
1992 |
S. Leonhardt |
4 |
Lil |
| | psilocin and bufotenin hum. vs. rat 5-HT2A binding data (ketanserin) |
| | x |
| | #464 |
Med. Chem. Res. |
3 |
52 |
1993 |
T. K. Gallaher |
4 |
Lil |
| | N1 substitution species variation 5-HT2A binding data |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
cloning of 5-HT2 receptors |
| cloning and distribution of a rat, hum. and mouse 5-HT2C receptor splice variant |
| | | | | #455 |
Mol. Pharmacol. |
50 |
799 |
1996 |
H. Canton |
4 |
Lil |
| | cloning of a gene involved in 5-HT receptor signal transduction or expression |
| | | | | #456 |
FEBS Lett. |
401 |
252 |
1997 |
S. Ohya |
4 |
Lil |
| | cloning and distribution of the hum. 5-HT2B receptor, 13 agonists and 22 antagonists binding data (DOI) |
| | x |
| | #458 |
FEBS Lett. |
352 |
393 |
1994 |
D.-S. Choi |
4 |
Lil |
| | 5-HT receptor nomenclature, especially 5-HT1B, 5-HT1Dalpha, and 5-HT1Dbeta |
| | | | | #459 |
TIPS |
17 |
103 |
1996 |
P. R. Hartig |
4 |
Lil |
| | | | | | | | | | | | | | 4 |
Lil |
binding theory |
| 5-HT2A receptor high affinity binding vs. efficacy, TM6 F340L mutation, bufotenine,
DMT, 5-MeO-DMT, 5-HT, alpha-Me-5-HT, DOM, (-)-DOB, DOI, and quipazine binding
(ketanserin) and IP accumulation data, ternary state receptor model |
| | x |
| | #457 |
J. Pharm. Exp. Ther. |
280 |
576 |
1997 |
B. L. Roth |
4 |
Lil |
| | | | | | | | | | | | | | 4 |
Lil |
DMT: agonist or antagonist |
| DMT as putative rat 5-HT1A agonist and rat 5-HT2A antagonist, DMT (+GTP) rat 5-HT1A (-OHDPAT) and rat 5-HT2A (ketanserin) binding data, AC inhibition and IP accumulation data |
| | x |
| | #462 |
Biochem. Pharmacol. |
41 |
1739 |
1991 |
A. V. Deliganis |
4 |
Lil |
| | | | | | | | | | | | | | | |
chromatography |
PRISMA solvent optimization |
PRISMA method for TLC solvent optimization |
| | | | | #466 |
J. Planar Chrom. |
1 |
336 |
1988 |
S. Nyiredy |
4 |
Lil |
| vacuum liquid chromatography |
vacuum liquid chromatography for simple, fast, and inexpensive separation of
closely related compounds |
| | | | | #538 |
J. Nat. Prod. |
49 |
934 |
1986 |
J. C. Coll |
5 |
Lil |
| vacuum liquid chromatography |
vacuum liquid chromatography for simple, fast, and inexpensive separation of
closely related compounds |
| | | | | #539 |
J. Nat. Prod. |
49 |
892 |
1986 |
S. W. Pelletier |
5 |
Lil |
| | | | | | | | | | | | | | | |
PTC imine C-alkylations |
glycine imines alkylations |
imines from glycine ester and 4-Cl-benzaldehyde or benzophenone, TBA-HSO4 and TEBA-Cl, various alkylhalogenides, aq. NaOH or ground KOH, CH2Cl2 |
| x |
| | | #477 |
Tet. Lett. |
23 |
4255 |
1982 |
M. J. O'Donnell |
4 |
Lil |
| alpha-Me-DOPA analogs |
imines from alanine ester or O-benzyltyrosines esters and 4-Cl-benzaldehyde or
mesityldehyde (against Pictet-Spengler), TBA-Br and TEBA-Cl, various
benzyloxylated benzylchlorides or methyl iodide, ground KOH, CH3CN or CH2Cl2 |
| x |
| | | #478 |
Tet. Lett. |
23 |
4259 |
1982 |
M. J. O'Donnell |
4 |
Lil |
| alpha-Me-histidine |
imines from alanine or tosyl-histidine ester and 4-Cl-benzaldehyde, TBA-Br,
acetoxymethyl-toyslimidazoline or methyl iodide, ground KOH, CH3CN |
| x |
| | | #479 |
Synth. Commun. |
19 |
1157 |
1989 |
M. J. O'Donnell |
4 |
Lil |
| stereoselective alpha-Me-AA |
imines from alanine-tert-butylester and subst. benzaldehyde, N-Bz.
chinchoninium chloride catalyst, subst. arylmethyl bromides, various bases
(NaOH, KOH or K2CO3), CH2Cl2 |
| x |
| | | #480 |
Tet. Asym. |
3 |
591 |
1992 |
M. J. O'Donnell |
4 |
Lil |
| alpha-alkyl-alanines and -phenylalanines |
imines from alanine-tert-butylester and subst. benzaldehyde, N-Bz.
chinchoninium chloride catalyst, subst. arylmethyl bromides, various bases
(NaOH, KOH or K2CO3), CH2Cl2 |
| x |
| | | #481 |
J. Am. Chem. Soc. |
111 |
2353 |
1989 |
M. J. O'Donnell |
4 |
Lil |
| 4-subst. 2-oxazolin-5-ones alkylation |
4-monosubst. 2-oxazolin-5-ones from various AA, TBA-Br, alkyl halogenides, aq.
Na2CO3, CH2Cl2 |
| x |
| | | #482 |
Synth. |
- |
763 |
1984 |
M. L. Gelmi |
4 |
Lil |
| AA imines alkylation and pKa |
imines from glycine and alanine esters and benzaldehyde, 4-Cl-benzaldehyde or
benzophenone, TBA-Br, benzylbromide, aq. NaOH or ground K2CO3, CH2Cl2, imines pKa |
| x |
| | | #483 |
J. Am. Chem. Soc. |
110 |
8520 |
1988 |
M. J. O'Donnell |
4 |
Lil |
| imino-acetonitrile alkylation |
imine from amino-acetonitrile and benzophenone, TEBA-Cl, various alkylbromides,
benzylchloride, or dimethyl sulfate, aq. NaOH, toluene |
| x |
| | | #484 |
Tet. Lett. |
47 |
4625 |
1978 |
M. J. O'Donnell |
4 |
Lil |
| AA alpha-alkylations |
imines from glycine and alanine esters and benzaldehyde, TEBA-Cl, various
alkylhalogenides, KOH and K2CO3, CH3CN or CH2Cl2, mechanism of PTC alkylation, base mixture optimization |
| x |
| | | #485 |
Tet. |
44 |
5343 |
1988 |
J. Yaozhong |
4 |
Lil |
| AA alpha-alkylations |
imines from glycine and alanine esters and 4-Cl-benzaldehyde or benzophenone,
TBA-Br, various alkylhalogenides, K2CO3, CH3CN |
| x |
| | | #486 |
Synth. |
- |
313 |
1984 |
M. J. O'Donnell |
4 |
Lil |
| 3-fluoro-phenylalanine from glycine |
imines from glycine esters and benzophenone, TBA-HSO4, alpha-F-benzylbromide, aq. NaOH, CH2Cl2 |
| x |
| | | #487 |
Tet. Lett. |
26 |
3067 |
1985 |
M. J. O'Donnell |
4 |
Lil |
| | | | | | | | | | | | | | | |
non-PTC imine C-alkylations |
glycine ethyl ester alkylation |
imines from glycine or alanine ethyl esters and benzaldehyde, anion with LDA /
hexamethyl phosphoramide or t-BuONa, alkylation with octyl iodide, butyl
bromide, isopropyl iodide, aldehydes and ketones from AA reduction with LiAlH4 and periodic acid cleavage, Michael addition of alkenes to imine |
| x |
| | | #496 |
J. Org. Chem. |
41 |
3491 |
1976 |
G. Stork |
4 |
Lil |
| alanine ester alkylation |
benzylidene alanine anion with LDA, alkylation with phtalimidoyl-alkyl iodides |
| x |
| | | #509 |
J. Med. Chem. |
21 |
50 |
1978 |
P. Bey |
4 |
Lil |
| Trp : pivalaldehyde imine, oxazolidinone |
imine from d-tryptophan and pivalaldehyde by stirring with NaOH and molecular
sieves in MeOH for 20 h, esterification and cyclization to oxazolidinone, anion
with LDA, alkylation with MeI, hydrolysis to (R)-alpha-Me-tryptophan |
| x |
| | | #510 |
J. Med. Chem. |
60 |
5719 |
1995 |
L. Zhang |
4 |
Lil |
| isocyano-Boc-Trp ester alkylation |
isocyano analog from formamido-Boc-Trp, anion with LDA, alkylation with alkyl
halogenides, hydrolysis, no reaction of benzylidene-Trp with higher alkyl
halogenides or of Boc-Trp ester benzophenone imine or Trp amidine ester with
even MeI |
| x |
| | | #512 |
Synth. |
- |
465 |
1990 |
D. Pettig |
4 |
Lil |
| isocyano AA ester alkylation |
isocyano-ester analogs of alanine, phenylglycine, and phenylalanine, anion with
NaH at RT, alkylation with alkyl dibromides, hydrolysis, cyclization to
proline-type AA |
| x |
| | | #513 |
Chem. Pharm. Bull. |
27 |
1931 |
1979 |
H. Yasuo |
4 |
Lil |
| arachidonate 2-alkylation |
methyl arachidonate, anion with LDA, alkylation with alkyl iodide |
| x |
| | | #514 |
Life Sci. |
56 |
2041 |
1995 |
I. B. Adams |
4 |
Lil |
| alanine ester alkylation |
imine from alanine and benzaldehyde, anion with NaH at RT or LDA, alkylation
with var. alkyl halogenides |
| x |
| | | #515 |
Tet. Lett. |
17 |
1455 |
1977 |
P. Bey |
4 |
Lil |
| alpha-halogenemethyl-AA |
imines from Ala, Lys, Orn, Met, Phe, Tyr, 3,4-diOH-Phe, His, or Arg ester,
anions (stable at RT) with LDA or NaH / hexamethylphosphoramide, alkylation
with MeI, CH2BrCl, MeClF2, hydrolysis |
| x |
| | | #516 |
J. Org. Chem. |
44 |
2732 |
1979 |
P. Bey |
4 |
Lil |
| AA imidine ester alkylation |
imidine esters from AA with DMF dimethyl acetal in one step, anion with LDA or
tBuOK, alkylation with alkyl halogenides or alkenes, hydrolysis, chelate
mechanism |
| x |
| | | #517 |
J. Org. Chem. |
42 |
2639 |
1977 |
J. J. Fitt |
4 |
Lil |
| | | | | | | | | | | | | | | |
tryptophan- or tryptamine-imines |
tryptophan ester imines |
tryptophan ester imine from tryptophan methyl ester, isovaleraldehyde and
molecular sieve, imine acylation with prolyl chloride. |
| x |
| | | #488 |
Tet. Lett. |
27 |
3235 |
1986 |
M. Nakagawa |
4 |
Lil |
| tryptophan - acetone imine |
imine from tryptophan and acetone under reflux for 40 h as a not isolated
intermediate |
| x |
| | | #495 |
Het. |
26 |
95 |
1987 |
M. F. Braña |
4 |
Lil |
| AA / arom. ketone imines |
AA imines from AA incl. Trp and Phe and 2-OH-acetophenone, -butyrophenone,
2,2'-OH-benzophenone, 2,2'-MeO-benzophenone, or 2,4-OH-benzophenone |
| x |
| | | #498 |
J. Chem. Soc. C |
- |
411 |
1968 |
A. F. Al-Sayyab |
4 |
Lil |
| tryptamine / cycloalkanone imines |
imines from tryptamine and cycloalkanones (C5-C8, TH-pyranon, TH-thiopyranon,
piperidinon) by refluxing in benzene with water trap for 5 h, Pictet-Spengler
reaction to beta-carbolines with H2SO4 or polyphosphoric acid |
| x |
| | | #499 |
J. Het. Chem. |
30 |
373 |
1993 |
J. G. Rodríguez |
4 |
Lil |
| tryptamine : naphtaldehyde imines |
imines from tryptamine and 1- or 2-naphtaldehydes or 4-pyridaldehyde by
precipitation after 10 min reflux in MeOH, Pictet-Spengler reaction to
beta-carbolines with HCl, imine reductions with H2, Pd/C, EtOH |
| x |
| | | #500 |
Can. J. Chem. |
45 |
2963 |
1967 |
B. T. Ho |
4 |
Lil |
| tryptamine : subst. benzaldehyde imines |
imines from tryptamine and 3-Meo-, 4-Meo- or 4-dimethylamino-benzaldehyde by
precipitation after 90 min reflux in MeOH, Pictet-Spengler reaction to
beta-carbolines with HCl, imine reductions with NaBH4 in EtOH, N-2-phenoxy- and N-benzyl-tryptamides and -amines |
| x |
| | | #501 |
Coll. Czech. Chem. Commun. |
28 |
629 |
1963 |
M. Protiva |
4 |
Lil |
| alpha-hydroxymethyl-tryptamine |
imine from alpha-hydroxymethyl-tryptamine and benzaldehyde by refluxing in
benzene and evaporation, alpha-hydroxymethyl-tryptamine from tryptophan ester
wit LiAlH4 |
| x |
| | | #502 |
Ber. |
91 |
2290 |
1958 |
H. Hellmann |
4 |
Lil |
| T / Trp ester imines, trimethylene Trp |
imines from tryptamine or tryptophan ester and (4-Cl or 4-NO2-) benzaldehyde or alkanals by stirring in CH2Cl2 / Et2O / MgSO4, Z-Trp ester formimine in situ from trimethylene tri(Z-Trp ester) and ZnCl2, |
| x |
| | | #503 |
Tet. |
49 |
397 |
1993 |
H. Waldmann |
4 |
Lil |
| tryptophan ester aldehyde imines |
imine from tryptophan ester and benzaldehyde by refluxing in benzene with water
trap, conditions and mechanism of Pictet-Spengler reaction to beta-carboline |
| x |
| | | #504 |
J. Org. Chem. |
49 |
2699 |
1984 |
M. Jawdosiuk |
4 |
Lil |
| tryptamine : acetone imines |
imines from (5-Meo-) tryptamine and acetone by refluxing in benzene with cat.
pTsOH and water trap, 6-MeO-tryptamine cyclized to beta-carboline, imine
cyclization with POCl3, Pictet-Spengler mechanism |
| x |
| | | #505 |
J. Org. Chem. |
29 |
2864 |
1964 |
J. B. Hester |
4 |
Lil |
| tryptamine : benzaldehyde imine reaction |
mechanism of Pictet-Spengler cyclization of benzylidene tryptamine with Lewis
acids |
| x |
| | | #506 |
Het. |
33 |
801 |
1992 |
T. Kawate |
4 |
Lil |
| tryptamine : benzaldehyde imine |
imine from tryptamine-HCl and benzaldehyde by refluxing in H2O / MeOH and NaOH addition, Pictet Spengler reaction to beta-carboline with HCl |
| x |
| | | #507 |
Anal. Chem. |
45 |
1536 |
1973 |
J. M. Lisy |
4 |
Lil |
| AA ester : isobutyraldehyde imines |
imines from all AA esters and isobutyraldehyde bisulfite addition product,
reduction with Zn / HCl, AA esters from AA with MeOH, thionyl chloride, not
checked for Pictet-Spengler reactions |
| x |
| | | #508 |
Anal. Chem. |
40 |
1910 |
1968 |
J. W. Davis, JR. |
4 |
Lil |
| beta-carbolines |
beta-carbolines from 5-MeO-, 5-MeO-N-Me-, 5-BzO-, 6-BzO-, and 7-BzO-tryptamine
and acetaldehyde, alpha-ketoglutaric acid, and pyridoxal,
5-MeO-N-Me-tryptamine from 5-Meo-N-Tos-tryptamine and MeI |
| x |
| | | #518 |
J. Med. Chem. |
7 |
135 |
1964 |
R. G. Taborsky |
4 |
Lil |
| | | | | | | | | | | | | | 4 |
Lil |
imine N-alkylation |
AA ester imine N-alkylation |
AA ester imines and amidines N alkylation with dimethylsulfate or
dimethyltriflate in CH2Cl2 or toluene |
| x |
| | | #489 |
Tet. Lett. |
25 |
3651 |
1984 |
M. J. O'Donnell |
4 |
Lil |
| benzaldehyde-PEA methylation |
imine from phenylethylamine and benzaldehyde (or vanilline), imine
N-methylation with MeI |
| x |
| | | #491 |
Ann. |
364 |
362 |
1909 |
H. Decker |
4 |
Lil |
| alkylimines methylation |
imines from alkylamine and benzophenone, imine N-methylation with MeI |
| x |
| | | #492 |
Compt. Rend. Acad. Sci. |
184 |
1338 |
1927 |
M. Sommelet |
4 |
Lil |
| benzylidenealkanes alkylation |
imines from lower alkylamines and benzaldehyde, imine N-methylation with
dimethyl- or diethylsulfate |
| x |
| | | #493 |
Acta Chem. Scand. |
15 |
1109 |
1961 |
K. A. Jensen |
4 |
Lil |
| bis-benzylidene-alkanes dimethylation |
imines from alkyldiamines and benzaldehyd, imine N-methylation with
dimethylsulfate, yields 85 - 99% |
| x |
| | | #494 |
Synth. |
- |
303 |
1980 |
F. Devínsky |
4 |
Lil |
| benzaldehyde-PEA methylation |
imine from PEA and benzaldehyde by distillation of H2O and educts without solvent, imine N-methylation with MeI in Et2O, dissolution in conc. HCl and steam destillation of benzaldehyde without
Pictet Spengler reaction (?) |
| x |
| | | #511 |
Arch. Pharm. |
? |
501 |
1924 |
S.
Osada |
4 |
Lil |
| | | | | | | | | | | | | | 4 |
Lil |
MeEtNH |
MePrNH |
MePrNH from tripropyl-trimethylene-triamine in quantitative yield, trimethyl-,
triethyl-, and tripropyl-trimethylene-triamine from aq. formaldehyde and aq.
alkylamine solutions in quantitative yields |
| x |
| | | #490 |
J. Chem. Soc. |
- |
1490 |
1931? |
J. Graymore |
4 |
Lil |
| unsym. sec. Alkylamines |
electrochemical reductive amination of various aldehydes with primary amines,
good yields |
| x |
| | | #197 |
J. Org. Chem. USSR (Engl.Transl.) |
28 |
374 |
1992 |
Yu. D. Smirnov |
3 |
Lil |
| triazine |
hexahydro-1,3,5-triazine from phenylglycine and formaldehyde with NaOH in
benzene / H2O |
| x |
| | | #520 |
Chem. Pharm. Bull. |
10 |
3985 |
1987 |
O. Nakaguchi |
5 |
Lil |
| | | | | | | | | | | | | | | |
stimulants |
pipradol and benzhydrylpiperidine analogs |
morpholine, pyrrolidyl, and azacycloheptane analogs of pipradol and
benzhydrylpiperidine, morpholines are the most active compounds |
x |
| | x |
| #530 |
J. Org. Chem. |
26 |
2834 |
1961 |
S. O. Winthrop |
5 |
Lil |
| pipradol analogs |
phenyl substituted and and heterocyclic pipradol analogs, mouse motor activity
data |
x |
| | x |
| #533 |
J. Am. Chem. Soc. |
79 |
472 |
1957 |
F. J. McCarty |
5 |
Lil |
| benzhydrol-pyridines |
benzhydrol-pyridines from 3-Br-pyridine, BuLi, and (
p
-Me/F/-Ph)2CO, or from 1-Br-2-MeO-benzene, Mg, and ethyl nicotinate, reduction with H2 / PtO2 / EtOH / HCl to benzhydryl-pyridines, benzhydryl-pyridines from PhCl and
pyridine-3-carbaldehyde with conc. H2SO4 |
| x |
| | | #558 |
CA |
64 |
14171e |
1966 |
R. H. Mizzoni |
5 |
Lil |
| N-acyl-2-diphenylmethyl-piperidines |
2-diphenylmethyl-piperidines N-acylation |
| x |
| | | #559 |
CA |
55 |
5548g |
1961 |
K. Hoffmann |
5 |
Lil |
| 2-diphenylmethyl-pyrrolidine |
2-diphenylmethyl-pyrrolidine from PhBr, Mg, and proline ethyl ester in anisole,
yield 23%, reduction with 1. HI in AcOH 2. Na2S2O3, yield 98%, rat activity data, ref. patent Fr. M. 3,638 1965 |
x |
| | x |
| #560 |
CA |
70 |
106375m |
1969 |
Roussel-UCLAF |
5 |
Lil |
| 2-diphenylmethyl-pyrrolidine |
2-diphenylmethyl-pyrrolidine from proline via N-ethoxycarbonyl-proline ethyl
ester with ClCO2Et, reaction with PhMgBr, and reduction with H2 / Pd/C / MeOH, total yield 67% |
x |
| | | | #561 |
Tet. Asym. |
8 |
149 |
1997 |
D. J. Bailey |
5 |
Lil |
| OH-pipradols |
2-diphenylmethyl-3-OR-piperidines from pyridinols with H2 / Raney Ni, NaOH / dioxane, N-Ac-, N-Me, N-Bz, N-PhCO, N-BzCO, O-Me, O-Ac,
O-EtCO, O-Me2NCO, mono-
p
-Cl, mono-
p
-MeO, cyclohexyl, and benzyl analogs, rat motor activity data |
x |
| | x |
| #562 |
J. Med. Chem.? |
11 |
792 |
1968 |
L. A. Walter |
5 |
Lil |
| heterocyclic pipradol and diphenylmethyl-piperidine analogs |
thienyl, pyrodyl, and piperidyl analogs of pipradol and
2-diphenylmethyl-piperidine, C-alkylated and NC,N-alkylated derivatives, rat
motor activity data |
x |
| | x |
| #563 |
Helv. Chim. Acta |
38 |
134 |
1955 |
J. Heer |
5 |
Lil |
| 2-diphenylmethyl-piperidine |
2-diphenylmethyl-piperidine, rat motor activity data |
x |
| | x |
| #564 |
Experientia |
10 |
261 |
1654 |
J. Tripod |
5 |
Lil |
| subst. 2-diphenylmethyl-piperidines |
subst. 2-diphenylmethyl-piperidines and analogs, rat motor activity data |
x |
| | x |
| #565 |
Helv. Chim. Acta |
37 |
2133 |
1954 |
E. Sury |
5 |
Lil |
| unsaturated 2-diphenylmethyl-piperidines |
subst. 2-diphenylmethyl-piperidines and analogs, reduction with Na / BuOH or
AmOH or with H2 / PtO or Ni, poor rat motor activity compared to 2-diphenylmethyl-piperidine |
x |
| | x |
| #566 |
Helv. Chim. Acta |
38 |
728 |
1955 |
E. Sury |
5 |
Lil |
| 1-Me-2-diphenylmethyl-piperidine via radical mech. |
1-Me-2-diphenylmethyl-piperidine from N-Me-6,6-diphenyl-5-hexenamine with 1.
1-oxa-2-oxo-3-thiazolinium chloride, yield 51% 2. Bu3SnH, light, and I2, yield 73% |
x |
| | | | #567 |
J. Am. Chem. Soc. |
117 |
11124 |
1995 |
J. H. Horner |
5 |
Lil |
| diarylmethanols reduction with NaBH4 in TFA |
subst. diarylmethanols reduction to diarylmethanes with NaBH4 in TFA, excellent yields |
| x |
| | | #568 |
Synthesis |
- |
172 |
1977 |
G. W. Gribble |
5 |
Lil |
| 2-diphenylmethyl-pyrrolidine |
2-diphenylmethyl-pyrrolidine from proline via B-Bz-proline ester with 1. SOCl2 / EtOH, 2. DCC, BzOH, yield 75%, N-Bz-pipradol with PhMgX, yield 75%,
2-diphenylmethyl-pyrrolidine with 1. Li / liquid NH3, yield 72% 2. H2 / Pd/C / EtOH, yield 91% |
x |
| | | | #569 |
Bull. Soc. Chim. Belg. |
97 |
691 |
1988 |
D. Enders |
5 |
Lil |
| subst. 2-benzhydrylpiperidines |
subst. 2-benzhydrylpiperidines from diphenylmethyl-pyridines,
benzhydryl-pyridines, or 1,1-diphenyl-5-CN-2-pentanone with with H2 / cat, from piperidyl-benzhydrol with LiAlH4, or from diphenyl-pyridyl-acetic acid or amide with H2SO4, ecpecially active are 1-Me-2-benzhydryl-piperidine and 2-(Ph-
p
-Cl-Ph-methyl)-piperidine, patent ref. Ger. 1,095,280 |
x |
| | x |
| #570 |
CA |
57 |
2197d |
1962 |
K. Hoffmann |
5 |
Lil |
| | (R)- and (S)-alpha-cyclohexyl-PEA and -N-Me-PEA via (1-Me-)
2-cyclohexyl-4-Ph-1,3-oxazolidine from alpha-phenylglycinol and
cyclohexyl-carbaldehyde, reaction with PhMgCl, debenzylation with H2 / Pd/C / AcOH, analgesic activity data, potent amphetamine activity of
S-isomer |
x |
| | x |
| #571 |
Chem. Pharm. Bull. |
34 |
2071 |
1986 |
H. Takahashi |
5 |
Lil |
| rac. alpha-cyclohexyl-PEA |
rac. alpha-cyclohexyl-PEA and unsaturated analogs via phenylacetylcyclohexene
from phenylacetylchloride and cyclohexene, benzylcyclohex-1-enyl ketoxime with
NH2OH, benzyl-cyclohexyl-ketone with H2 / Pd/C / EtOH / HCl, oxime, reduction with LiAlH4, rat anorexia and motor activity data, mice LD50 data, medium rat motor activity inhibition at
1
/10 LD50 |
x |
| | x |
| #572 |
Drug. Res. |
28 |
1561 |
1978 |
P. Ghosh |
5 |
Lil |
| methamphetamine from imine and PhMgCl |
methamphetamine from methylamine, acetaldehyde, and BzMgCl, yield ca. 40% |
x |
| | | | #573 |
Gazz. Chim. Ital. |
77 |
318 |
1947? |
V. Evdokìmoff |
5 |
Lil |
stimulants |
thiamorpholinyl pipradol analog |
thiamorpholinyl pipradol analog from thiamorpholin-2-carboxylate and Ph-MgBr,
mouse motor activity data |
x |
| | x |
| #536 |
J. Med. Chem. |
2 |
553 |
1960 |
D. Belleau |
5 |
Lil |
| 2-amino-1,2-dihydronaphtalene |
2-amino-1,2-dihydronaphtalene, mouse motor activity data |
x |
| | x |
| #537 |
J. Med. Chem. |
25 |
535 |
1982 |
B. A. Hathaway |
5 |
Lil |
| psychotomimetics review |
extensive psychotomimetics review, many references, stimulant reviews in the
same volume |
| | | x |
| #544 |
Handbook of Psychopharmacology, Stimulants, Ed. L. L. Iversen, Plenum Press, NY |
11 |
243 |
1987 |
A. T. Shulgin |
5 |
Lil |
| | | | | | | | | | | | | | | |
indole Grignard |
indole Grignard, indolylacetone |
3-allyl-indole from indolyl-MgBr and allyl bromide, yield 70%,
3-indolylacetaldehyde, 3-indolylacetone from IAA with 1. Ac2O / NaOAc, yield 49% 2. MeONa, yield 55% |
| | | | | #547 |
J. Chem. Soc. |
- |
3172 |
1952 |
J. B. Brown |
5 |
Lil |
| | | | | | | | | | | | | | | |
blockers |
4-piperidyl-benzhydrol blocks LSD |
(4-piperidyl)-diphenyl-methanol blocks LSD effects in human |
| | | x |
| #545 |
Science |
121 |
208 |
1955 |
H. D. Fabing |
5 |
Lil |
| DMT and LSD blockers |
diethyl-alkyamides as blockers and enhancers of DMT, DOM, and mescaline
activity, rat Bovet-Gatti profile activity data, enormous doses used, ref. to:
LSD blocker THPC: J. R. Smythies (Ed.) The Mode of Action of Psychotomimetic
Drugs, NRP Bull. 8, 1 1970 |
| | | x |
| #343 |
Eur. J. Pharmacol. |
17 |
270 |
1972 |
J. R. Smythies |
4 |
Lil |
| | | | | | | | | | | | | | |
|